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Xylose is the second most abundant sugar in cellulosic hydrolysate. Xylose 
utilization has been extensively studied in both microbes that naturally utilize it, for 
example Escherichia coli and Scheffersomyces stipitis, as well as in model organisms that 
have abundant genetic tools such as Saccharomyces cerevisiae. However, in non-
conventional microorganisms that possess great industrial potential, only minimal research 
has been conducted to enable and improve their xylose utilization. In this study, we chose 
Yarrowia lipolytica as an example to explore threekey strategies to enable xylose 
utilization by a non-catabolizing host for the purposes of producing a variety of value-
added chemicals.  
First, we integrated two heterologous genes that are essential for xylose utilization. 
Introduction of the pathway itself was not enough to enable xylose utilization, so a 
starvation-enabled adaptation was used to activate the pathway and kick-start xylose 
catabolism. Through whole genome sequencing, we found the copy numbers of both genes 
were multiplied during starvation. The resulting strain was able to produce 15g/L lipid from 
 viii 
xylose in bioreactors. We then tested several targets within the pentose phosphate pathway 
that have been shown to improve xylose utilization in S. cerevisiae. Among these, only 
native xylulose kinase overexpression was shown to effectively improve xylose utilization 
in Y. lipolytica. Next, we utilized this strain to expand the product portfolio from xylose 
through the use of a strain mating approach. Specifically, we altered the native mating type 
within this strain and mated it with three separately engineered strains of Y. lipolytica that 
overproduce α-linolenic acid, riboflavin or triacetic acid lactone. The mated diploid strains 
were able to produce all three products from xylose in high quantities. Finally, we turn to 
the first step of xylose catabolism, transport into the cell, to remove a common bottleneck. 
To do so, we utilized a series of evolution and selection steps to engineer a xylose 
transporter that is uninhibited by glucose when transporting xylose. This transporter can 
ultimately enable yeasts to co-utilize glucose and xylose.  
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Chapter 1:  Introduction and background 
1.1 LIGNOCELLULOSIC BIOMASS AND HYDROLYSATE 
Continued use of fossil fuels are unsustainable and human kind needs to find 
alternatives to this source of energy(Jones and Warner 2016). Bioenergy, along with solar 
energy, wind energy, hydropower and geothermal energy are the major renewable energies 
being explored to diversify our available energy sources(David Martin Alonso 2011; Dale 
and Ong 2012). However, fossil fuels are not only sources for energy, but are used as 
starting materials for plastic, synthetic rubber, chemical solvents, fabric, detergents, 
cosmetic products, pharmaceutical components and even food preservatives (Naik et al. 
2010). In all of those products, fossil fuels provide physical material, which people are not 
able to obtain from sunlight, wind, flowing water, or heat from Earth (Tai 2012). However, 
biology can produce a diverse array of these physical substances from various carbon 
sources (Quinn and Davis 2015). Glucose is one of the most abundant sustainable carbon 
sources since it is the primary product from photosynthesis. Common glucose sources are 
sugar cane juice which is rich in glucose monomers, or hydrolysed corn or other crops that 
are high in starch. Both are currently commercially used for making bio-ethanol (Lynd 
1996). Moreover, glucose from plant sources can provide a renewable source of carbon for 
bioproduction of a great number of compounds using engineered microorganisms (David 
Martin Alonso 2011). However, biofuels generated from crops, which are called first-
generation biofuel, directly compete with food supplies(Naik et al. 2010). This competition 
has raised food prices in the international market in the past (McMichael 2010; Mol 2010). 
Thus, the search for cheap, non-competitive carbon sources led scientists to focus on non-





Lignocellulosic biomass is dry plant matter used as the carbon source for second-
generation biofuel (Naik et al. 2010; Brethauer and Studer 2015; Marriott, Gómez and 
Mcqueen-Mason 2016). The three main sources for lignocellulosic biomass are agriculture 
waste, energy crops, and wood (Lynd 1996). The most common agriculture wastes are corn 
stover, wheat straw, or rice straw (Donato et al. 2015). Energy crops are plants that can 
grow on marginal land that are not suitable for food crops, and produce high amount of 
biomass (Clifton-Brown et al. 2019). The most widely studied energy crop is switchgrass, 
which produces very large amount of biomass. Native prairie plants have also been studied 
for their environmental benefits (Boe and Lee 2007). The wood source for lignocellulosic 
biomass can be either hardwood, like poplar, or softwood, like pine trees (Przybysz Buzała 
et al. 2017).   
On the structural/chemical level, lignocellulosic biomass is composed of three main 
components: cellulose, hemicellulose and lignin (Jin et al. 2013; Mcqueen-mason 2015; 
Marriott, Gómez and Mcqueen-Mason 2016). The specific ratio of these three components 
varies depend on the biomass source. All three components are polymers. Cellulose is 
polymer of glucose; hemicellulose is polymer of mainly pentose with hexose side chains 
and lignin is polymer of a group of aromatic compounds. Lignocellulose is generally 
pretreated prior to use to break down the polymeric material to monosaccharides 
(Chiaramonti et al. 2012; Zheng and Rehmann 2014). There are many types of pretreatment 
available, including physio-chemical pretreatment like ammonia fiber explosion (AFEX) 
(Balan et al. 2009), autohydrolysis (steam explosion) (Amiri and Karimi 2015), acid or 
alkali treatment (Takács et al. 2000; Iranmahboob, Nadim and Monemi 2002); chemical 
pretreatment like ionic liquids (Da Silva et al. 2013) or gamma-valerolactone (GVL) 
(Luterbacher et al. 2014); and enzymatic treatment with cellulase and hemicellulase 
(Zhang and Lynd 2006). After pretreatment, lignocellulosic biomass generally turns into a 
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dark, coffee-like liquid with contaminating material that could not be broken down. The 
residue is mostly lignin-derived compounds that unfortunately (at present) not effectively 
used to produce biochemicals at high level by human (Frei 2013). The dark liquid is called 
hydrolysate. Hydrolysate is a solution that contains high amount of sugars and also many 
other types of organic molecules including molecules that support cell growth and also 
many aromatic compounds that can inhibit microbial growth (Jin et al. 2013; Xue et al. 
2018). The most abundant sugar in hydrolysate is glucose, and the second most abundant 
sugar is xylose(Gírio et al. 2010). This hydrolysate is used for microbial cell growth to 
produce the second-generation biofuel or other chemical molecules.  
1.2 XYLOSE METABOLIC PATHWAY 
Xylose (C5H10O5) is a pentose sugar that makes up the polymer backbone for 
hemicellulose (Hilpmann et al. 2016). Within lignocellulosic hydrolysate, the average 
amount of xylose can reach to about 50% of the amount of glucose in hydrolysate (Gírio 
et al. 2010; Jagtap and Rao 2018). Additional sugars, for example, arabinose, mannose or 
galactose together make up a very small portion of the soluble sugar in hydrolysate (David 
Martin Alonso 2011; Jin et al. 2015a). Thus, if an industrial microorganism can use both 
glucose and xylose to make its product, the overall titer can increase up to 50% as compared 
to using glucose only. However, many of the microorganisms that are commonly used in 
industry including the main two either do not use xylose effectively (E. coli) (Ammar, 
Wang and Rao 2018) or not at all (S. cerevisiae) (Salusjärvi et al. 2008). This great 
potential leads many scientists around the world to study how to decode the ways for 
microbes to utilize xylose effectively.  
Throughout the years, scientists have made significant progress on improving 
xylose utilization in microorganisms. The xylose utilization metabolic pathways have been 
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studied in microorganisms that naturally consume xylose and the enzymes catalyze these 
pathway reactions have been introduced into non-xylose utilizing model organisms like S. 
cerevisiae(Walfridsson et al. 1995; Anderlund, Rådström and Hahn-Hägerdal 2001; Jin 
and Alper 2005; Matsushika et al. 2009). There have been two main xylose pathways found 
and deeply studied, the oxido-reductase pathway and the isomerase pathway. The oxido-
reductase pathway converts xylose into xylulose in two steps. First a xylose reductase (XR) 
converts xylose into xylitol, and then a xylitol dehydrogenase (XDH) converts xylitol into 
xylulose (Jeffries and Jin 2004). The isomerase pathway uses a single isomerase to directly 
convert xylose into xylulose, the common product for both pathways (Lee, Jellison and 
Alper 2012). Xylulose is then converted by action of a xylulose kinase (XKS) to xylulose-
5-phosphate, which is incorporated into the native pentose phosphate pathway (Scalcinati 
et al. 2012). The microorganisms can then use their native genes to metabolize xylulose-
5-phosphate.  
1.3 YARROWIA LIPOLYTICA AS A CELL FACTORY 
Yarrowia lipolytica is an oleaginous yeast emerging as one of the industry favorite 
non-conventional yeasts studied by both industrial and academic research groups (Blazeck 
et al. 2014; Gonçalves, Colen and Takahashi 2014; Liu et al. 2015a). Isolated from cheese 
(Roostita and Fleet 1996), Y. lipolytica has many desired properties for biochemical 
production (Palmer and Alper 2019). Like all oleaginous yeasts, Y. lipolytica is a natural 
high lipid producer. By applying the strategies of metabolic engineering, Y. lipolytica can 
produce nearly 99g/L lipid in bioreactor settings (Qiao et al. 2017). Lipids produced by 
this (and other) yeast can be transesterified with short chain alcohols to afford a mixture of 
compounds called biodiesel(Adesanya et al. 2014). Biodiesel can be used in diesel engines 
without making modifications on the engine (Abu-Hamdeh and Alnefaie 2015). Biodiesel 
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can also be used as aviation fuel (Taheripour et al. 2010). In contrast to bio-ethanol, which 
is easily outpaced by the use of batteries in electronic vehicles, biodiesel is more difficult 
to replace with alternative fuels for their use in aircrafts and railroads, and also their 
competitiveness in price (Carlson 2007). Besides lipids, Y. lipolytica has also been used for 
both protein and citric acid production (Gonçalves, Colen and Takahashi 2014). Recent 
research has also expanded the product portfolio to other oleochemicals like poly-
unsaturated fatty acids or fatty alcohols (Cordova and Alper 2018), other organic acids like 
α-ketoglutaric acid, pyruvic acid, succinic acid and itaconic acid (Blazeck et al. 2015; Ryu, 
Hipp and Trinh 2015); other nutraceuticals like lycopene, β-carotene, (Matthäus et al. 2014; 
Czajka et al. 2018); and products derived from Acetyl CoA, like type III polyketides 
(Markham et al. 2018).  
1.4 ENABLING XYLOSE UTILIZATION IN Y. LIPOLYTICA 
With such wide applications in chemical production, there remains one significant 
issue with Y. lipolytica: it does not naturally utilize xylose as a carbon source. The inability 
to use xylose limits the titer of products that can be produced from Y. lipolytica. Sequencing 
results have shown that a native XR and XDH are present in Y. lipolytica genome. However, 
Y. lipolytica is not able to natively grow in media in which xylose is the only carbon source 
(Ryu, Hipp and Trinh 2015). Some preliminary research has shown that a drop of xylose 
level can be detected after Y. lipolytica grows to high cell density when glucose was present, 
hinting that xylose utilization is possible in Y. lipolytica. Some early attempts to integrate 
xylose catabolic pathways into Y. lipolytica, however, did not result in a xylose utilization 
strain. The work detailed in Chapter 2 describes the successful construction of a xylose-
utilizing Y. lipolytica strain. Xylose-catabolism was realized only after a starvation process 
which duplicated the copy numbers of xylose pathway genes that result in higher 
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expression levels. The xylose utilizing strain was able to make more than 15 g/L lipid when 
xylose was provided as the only carbon source in bioreactors. These results were published 
in Biotechnology Journal in 2016.  
1.5 IMPROVING XYLOSE UTILIZATION THROUGH METABOLIC ENGINEERING 
After Y. lipolytica was made to be able to use xylose, we sought to improve this 
phenotype through additional metabolic engineering. Similar to Y. lipolytica, S. cerevisiae 
also cannot grow on xylose naturally, and after integration of xylose pathway genes into S. 
cerevisiae, it has been discovered that xylose utilization was not at maximum capacity due 
to inhibition, co-factor imbalance or metabolic bottle-necks (Sànchez Nogué and 
Karhumaa 2015). Scientists have identified a handful of targets that improve xylose 
utilization in S. cerevisiae, including xylulose kinase that is downstream of the integrated 
pathway and genes in pentose phosphate pathway (Walfridsson et al. 1995; Karhumaa, 
Hahn-Hägerdal and Gorwa-Grauslund 2005; Salusjärvi et al. 2008). The native versions of 
those genes were found in Y. lipolytica and tested in Chapter 3, along with additional genes 
that were hypothesized to be able to balance the co-factors in Y. lipolytica in xylose 
pathway. Our results demonstrate that native xylulose kinase overexpression most 
significantly improves xylose utilization in Y. lipolytica.  
1.6 EXPANDING THE PRODUCT PORTFOLIO FROM XYLOSE IN Y. LIPOLYTICA THROUGH 
MATING 
One of the major advantages of Y. lipolytica is its diverse product portfolio. To 
achieve high product titers, many high production strains have undergone significant 
genetic modification, mutation and selection, or adaptation. Similarly, our xylose 
utilization strain also went through heterologous and homologous genes overexpression 
and starvation adaptation. Due to the limitation of genetic modification tools for Y. 
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lipolytica, transferring desirable phenotypes into a new strain background and maintaining 
effective expression levels presents a unique challenge (Liu et al. 2015a; Wagner and Alper 
2015; Abdel-Mawgoud et al. 2018). To make products other than lipids from xylose, we 
used traditional mating methods to combine traits from different strains. Y. lipolytica have 
two mating types, type A and type B (Weber, Kurischko and Barth 1988; Barth 2011). Y. 
lipolytica is not able to switch mating type like S. cerevisiae, so we altered the xylose 
utilizing strain from mating type A into mating type B. The xylose strain after mating type 
switch was mated with three mating type A strains that produce drastically different 
products: α-linolenic acid, riboflavin and triacetic acid lactone. The mated diploid strain 
has high stability and produce very satisfying titer of products from xylose while 
maintaining titer from glucose. This work in Chapter 4 shows that mating can be a reliable 
method for expanding Y. lipolytica product portfolio.  
1.7 ENGINEERING XYLOSE TRANSPORTER WITHOUT GLUCOSE INHIBITION 
One major issue for xylose utilization in microorganisms is that xylose utilization 
is inhibited by the presence of glucose (Subtil and Boles 2012; Farwick et al. 2014a). This 
phenotype has been observed in both Y. lipolytica and S. cerevisiae . Removing this glucose 
inhibition and allowing for glucose/xylose co-utilization can greatly increase fermentation 
efficiency. In Chapter 5, we demonstrated starting from an engineered xylose-only 
transporter, through multiple rounds of random mutagenesis, we were able to identify a 
few key residues that are related to glucose inhibition on xylose. In a model strain in which 
all other monosaccharide transporters were removed, this mutant transporter exhibited the 
capacity to transport both glucose and xylose with no inhibition to each other, but showed 
preference to xylose. This work was conducted in S. cerevisiae, and published in Applied 
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Microbiology and Biotechnology in 2016. This transporter can be further tested and applied 
in other xylose utilizing yeast strains.  
1.8 SUMMARY 
Due to the limited use of model yeast S. cerevisiae, scientist have drifting their 
focus away to other non-conventional yeasts for biochemical production. Among the non-
conventional yeast, Y. lipolytica has drawn great attention due to its metabolic advantage 
and diversity in products making. In this work, we showed three complementary strategies 
involved in engineering Y. lipolytica into an effective xylose utilizing production host. The 
three steps include first introducing and activating xylose catabolic pathway; product 
portfolio expansion; and finding other targets to further improve xylose utilization. During 
the engineering process, we encountered many obstacles that are normally not seen in S. 
cerevisiae. To solve those problems, we used a combination of modern techniques like 
whole genome sequencing, site directed mutagenesis; traditional techniques like starvation 
induced adaptation, mating; as well as some new tools recently transplanted into Y. 
lipolytica system like piggyBac transposase to achieve our goal. In the end, we were able 
to obtains Y. lipolytica strains that are able to make 15 g/L lipid, 0.52 g/L α-linolenic acid, 
96.6 mg/L riboflavin and 2.9 g/L triacetic acid lactone respectively as long as a transporter 
that are able to transport xylose and glucose simultaneously without inhibition to each 
other. This study can be used as a general guideline on how to enable a non-conventional 
yeast to utilize a non-native carbon source. 
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Chapter 2:  Enabling xylose utilization in Yarrowia lipolytica for lipid 
production11 
2.1 CHAPTER SUMMARY 
The conversion of lignocellulosic sugars, in particular xylose, is important for 
sustainable fuels and chemicals production.  While the oleaginous yeast Yarrowia 
lipolytica is a strong candidate for lipid production, it is currently unable to effectively 
utilize xylose.  By introducing a heterologous oxidoreductase pathway and enabling 
starvation adaptation, we obtained a Y. lipolytica strain, E26 XUS, that can use xylose as a 
sole carbon source and produce over 15 g/L of lipid in bioreactor fermentations (29.3% of 
theoretical yield) with a maximal lipid productivity of 0.19 g/L/h.  Genomic sequencing 
and genetic analysis pointed toward increases in genomic copy number of the pathway and 
resulting elevated expression levels as the causative mutations underlying this improved 
phenotype.  More broadly, many regions of the genome were duplicated during starvation 
of Yarrowia.  This strain can form the basis for further engineering to enhance xylose 
catabolic rates and conversion.  Finally, this study also reveals the flexibility and dynamic 
nature of the Y. lipolytica genome, and the means at which starvation can be used to induce 
genomic duplications. 
2.2 INTRODUCTION 
An increased demand for energy and materials over the past few decades (Jones 
and Warner 2016) has been matched with depleting reserves of traditional fossil fuel, 
despite new mining technologies (Milano et al. 2016).  To address this need, a significant 
                                                 
1 Content in this chapter adapted from a previously authored publication written by HL. HL equally 
contributed to the contributed to experiments, analyses and writing of the manuscript.  
Haibo Li and Hal S. Alper, 2016. Enabling xylose utilization in Yarrowia lipolytica for lipid production. 
Biotechnology Journal 11(9)1230-40. 
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amount of research has been placed on identifying alternative sources for liquid 
transportation fuels and chemicals, especially from lignocellulosic biomass (Lynd 1996; 
Naik et al. 2010; Brethauer and Studer 2015; Jin et al. 2015b; Mcqueen-mason 2015; 
Quinn and Davis 2015).  Lignocellulosic hydrolysate (typically sourced from corn stover 
or switchgrass) is normally comprised of 60-70 g/L glucose and 30-40 g/L xylose (Pauly 
and Keegstra 2008).  While the glucose portion can efficiently and rapidly be converted 
into fuel molecules by microbes, very few organisms are readily able to utilize xylose as 
effectively (Wang, Shopsis and Schneider 1980; Jeffries 1983; Jeffries and Jin 2004; 
Young, Lee and Alper 2010; Harner et al. 2015).  As a result, metabolic engineering 
strategies for enabling microorganisms to use xylose has been the focus of research in the 
field (Jeffries and Jin 2004; Young, Lee and Alper 2010; Scalcinati et al. 2012; Parreiras 
et al. 2014; Harner et al. 2015; Ryu, Hipp and Trinh 2015; Sànchez Nogué and Karhumaa 
2015).  
One particular microbe of interest for biofuels production is the oleaginous yeast 
Yarrowia lipolytica due to its high capacity to convert glucose into lipids, a potential 
feedstock for biodiesel (Tai 2012; Blazeck et al. 2014; Gonçalves, Colen and Takahashi 
2014).  Additionally, Y. lipolytica has the potential to be a host system for a variety of 
other biochemical products (Nicaud et al. 2002; Blazeck et al. 2013a, 2015; Liu, Redden 
and Alper 2013).  Previous results from the Alper lab have demonstrated that a 
combination of metabolic engineering and adaptive evolution can rewire Y. lipolytica to 
produce high titers (approaching 40 g/L) of lipids with cells containing nearly 90% of 
biomass as lipids (Liu et al. 2015b).  However, the use of Y. lipolytica as a host cell 
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capable of utilizing lignocellulosic hydrolysate is complicated by the inability of this 
organism to effectively utilize xylose as a primary carbon source.  Prior work has 
demonstrated engineering to enable some xylose utilizing capacity for this cell, however, 
the resulting strain did not grow well on xylose and the xylose utilization phenotype was 
not stable (Ryu, Hipp and Trinh 2015).  Prior results from our laboratory indicate that 
xylose can be converted into lipids only when cells are transferred in stationary phase into 
high concentrations of xylose (Blazeck et al. 2014).  Even still, this cell is unable to use 
xylose as a primary source for conversion to biomass.  Additional literature and research 
findings also corroborates the findings that xylose catabolism is not fastidious in this 
organism.  Thus, pathway engineering is necessary to improve the xylose catabolic 
phenotype in Y. lipolytica. 
Xylose catabolism can be achieved by two major pathways: the oxidoreductase 
pathway and the isomerase pathway (Young, Lee and Alper 2010).  Both of these 
pathways have been well-described and documented previously (Jeffries 1983; Jeffries and 
Jin 2004).  Briefly, the oxidoreductase pathway (most studied from Scheffersomyces 
stipitis) consists of two major steps to first convert xylose into xylitol by xylose reductase 
(XYL1), and then xylitol into xylulose by xylitol dehydrogenase (XYL2).  In the isomerase 
pathway (initially identified in Lactobacillus pentosus and studied from Escherichia coli 
and Piromyces sp.) consists of one step that reversibly converts xylose into xylulose by 
xylose isomerase (XylA).  In both pathways, the resulting xylulose is then phosphorylated 
by xylulokinase (XYL3) into xylulose-5-phosphate before entering the pentose phosphate 
pathway.  Among these two pathways, Y. lipolytica has putative genes for XYL1, XYL2 
 12 
and XYL3, but only XYL3 has been proven to be functional and expressed (Ryu, Hipp and 
Trinh 2015).  In a previous report, activation of the endogenous XYL1 and XYL2 genes in 
Y. lipolytica was possible, albeit with a poor resulting growth rate and strain stability (Ryu, 
Hipp and Trinh 2015).  As a result, it is likely that heterologous pathways would enable 
Y. lipolytica to utilize xylose stably and efficiently. 
In this study, we evaluate both potential pathways for xylose catabolism in Y. 
lipolytica and demonstrate that codon-optimized versions of S. stipitis XYL1 and XYL2 can 
function in Y. lipolytica.  In contrast, a codon-optimized version of the isomerase pathway 
was not found to be active.  Next, we demonstrate that an adaptive, evolutionary 
engineering period (induced by starvation) is necessary to generate cells that can optimally 
use xylose in a stable manner.  Through genome resequencing, we find that this efficient 
phenotype was predominately enabled by gene duplications in the XYL1 and XYL2 to allow 
for higher expression levels.  By performing this optimization in a previously engineered 
lipid overproducing strain (E26), we demonstrate the capacity of the resulting cells to 
produce 15 g/L of lipids with productivities of 0.19 g/L/h in bioreactor fermentations of 
xylose.  This represents a nearly 30% conversion yield of xylose and demonstrates the 
potential to enable xylose catabolism in Y. lipolytica for fuels and chemicals production. 
2.3 RESULTS  
Initial benchmarking growth assays were performed with strains and in contrast to 
previous reports (15, 32, 33), we found that Y. lipolytica strains PO1f and E26 were unable 
to grow in minimal media with xylose as the only carbon source. This result is consistent 
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with additional reports in literature (Ruiz-Herrera and Sentandreu 2002; Pan et al. 2009).  
Our previous results demonstrating xylose conversion in stationary phase cells (Blazeck et 
al. 2014) suggests an unknown regulation and temporal activation of the endogenous 
oxidoreductase pathway.  To avoid any of these complications, we opted to utilize 
heterologous pathway expression of both the oxidoreductase pathway (codon-optimized 
XYL1 and XYL2 from S. stipitis) and the isomerase pathway (codon-optimized XylA from 
Piromyces sp.).  Initial tests were conducted to determine the effectiveness of these 
pathways. 
2.3.1 Heterologous oxidoreductase pathway complementation and starvation 
enables xylose catabolism 
Heterologous xylose pathways were introduced into both the wild-type (PO1f) and 
engineered (E26) strains of Y. lipolytica.  Complementation of either pathway 
(oxidoreductase or isomerase) was insufficient to enable growth of any strain of Y. 
lipolytica.  Thus, we sought to perform a starvation-enabled adaptive evolution.  
Specifically, each of these strains were grown in glucose and allowed to sit in carbon-
depleted medium for 14 days.  After this time, starved cells were washed with water, and 
then transferred into fresh 50 mL cultures of YNB with 20 g/L xylose.  After 12 days of 
culture, strains complemented with the oxidoreductase pathway were able to consume all 
of the xylose present.  This phenomenon occurred with both the wild-type (PO1f) and 
engineered (E26) strains.  In contrast, this utilization was not seen with the isomerase 
strains as starved cells showed no difference in OD after incubated in xylose for 12 days 
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and no xylose consumption could be measured. This indicates that codon-optimized 
isomerase does not work in Y. lipolytica without further engineering.  
Next, individual colonies adapted from the oxidoreductase pathway were isolated 
and screened for their capacity to grow on xylose.  In particular, seven individual colonies 
isolated from the adapted engineered strain were confirmed to have strong xylose catabolic 
features and thus were further characterized in shake flasks (Figure 2-1).  The diverse 
growth patterns observed among these strains suggests that they may not be genetically 
identical and thus may represent unique evolutionary trajectories.  The best performing 
strain was renamed E26 XUS (the E26 Xylose Utilizing Strain) and was selected for further 
characterization including fermentation capacity and genome resequencing. 
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Figure 2-1: Growth profiles of isolated Y. lipolytica strains on 20 g/L xylose. 
 
(A) Growth curves of all seven isolated E26 derived strains expressing XYL1 and XYL2 
after starvation are shown compared with PO1f, E26 Ura- Leu- and E26 XYL1XYL2 as 
controls. (B) The full growth curve of the E26 XUS strain is shown with the same controls 
as in (A). Each data point represents an average ± 1 standard deviation of three biological 
replicate experiments that were grown in parallel. 
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2.3.2 E26 XUS enables high lipid production in bioreactors 
Following isolation, we sought to evaluate the lipid production traits of the E26 
XUS strain in a bioreactor setting.  For this experiment, we selected the controlled pH, 
temperature and dissolved oxygen settings previously found optimal for lipid production 
using glucose as carbon source (Blazeck et al. 2014).  Moreover, to best compare the 
resulting performance to the parental strain on glucose, we used the same media 
formulation swapping glucose for xylose.  Specifically, this media contained 160 g/L 
xylose, 10 g/L ammonium sulfate, and YNB (Liu et al. 2015b). The resulting fermentation 
was able to reach an OD600 of 100 within 120 hours and all xylose was consumed before 
216 hours (Figure 2-2).  While these cultures seemed to lag by nearly 24 hours compared 
to growth on glucose, these results demonstrate the strongest growth of Y. lipolytica on 
xylose reported to date.  Total lipid production of just over 15 g/L was achieved (Table 
2-1) with a maximal lipid productivity of 0.19 g/L/h realized.  A lipid content of mainly 
C18 and C16 fatty acid species were found when converting xylose into lipids (Table 2-1) 
which is similar to the composition seen with glucose conversion (Blazeck et al. 2014).  
Collectively, this strain was able to achieve 29.3% of the theoretical yield of xylose into 
lipids.  While these overall metrics lag those achieved in glucose, they represent a strong 
initial xylose catabolic capacity that has not been previously reported. 
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Table 2-1: Lipid production data from last time point of bioreactor fermentation.  
16:0 16:1 18:0 18:1 18:2 Total (g/L) 




Figure 2-2: Bioreactor fermentation of the E26 XUS strain in xylose. 
 
 
Growth curve, xylose utilization data and lipid production data in 1.5 L bioreactor 
fermentations. Each data point represents an average ± 1 standard deviation of three 




2.3.3 XYL1 and XYL2 are highly expressed in the XUS strain 
Next, we performed a series of genetic analysis in an effort to identify the causative 
genetic factors leading to the xylose catabolic phenotype observed here.  First, we 
performed focused Sanger sequencing of the XYL1 and XYL2 genes present in PO1f 
XYL1XYL2, PO1f XUS, E26 XYL1XYL2, and E26 XUS strains. Surprisingly, no mutations 
were found in any of these strains, indicating that the xylose catabolic phenotype was not 
due to mutations in the enzymes. 
After pathway specific mutations were ruled out, we next evaluated the expression 
level of these enzymes across the strains and conditions.  Previous work suggests that 
endogenous, putative XYL1 and XYL2 can be upregulated in xylose utilizing strains (Ryu, 
Hipp and Trinh 2015).  Moreover, an additional study suggests that heterologous 
expression of xylose pathway enzymes can have higher expression than endogenous XYL1 
and XYL2 (Tai 2012).  To evaluate expression of our heterologous enzymes, we 
conducted RT-PCR.  Specifically, we observed that the expression level of exogenous 
XYL1 and XYL2 in starvation-treated E26 XUS strains is indeed much higher than in the 
E26 XYL1XYL2 strain before starvation (Figure 2-3). We also measured the XYL3 
expression level under the same condition, and observed no substantial changes of XYL3 
expression between the strains (Figure 2-3). The expression of XYL1 and XYL2 was 
consistent regardless of whether the cells were grown in glucose or xylose, a trait that is 
expected due to the constitutive TEF-based promoter used to drive expression.  Thus, 
these results indicate that expression of XYL1 and XYL2 increased 6-fold and more than 
10-fold, respectively in the evolution of the E26 XUS strain. 
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Figure 2-3: Expression levels of XYL1, XYL2 and XYL3. 
 
 
Relative mRNA expression levels of XYL1, XYL2 and XYL3 at exponential phase in 50 mL 
of CSM in 125 mL flask for strain E26, E26 XYL1XYL2 and E26 XUS were measured with 
RT-PCR. E26 and E26 XYL1XYL2 were grown on glucose. E26 XUS was grown on either 
glucose or xylose. Actin DNA copy number was used as internal reference. The expression 
level of XYL1 and XYL2 is shown with the primary axis on the left, and expression level of 
XYL3 is shown with secondary axis on the right. Each data point represents an average 
value ± 1 standard deviation calculated from the results of three biological replicates. 
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2.3.4 Genome resequencing reveals XYL1 and XYL2 duplication as a major factor 
for improved xylose consumption 
To further understand the underlying genetic changes responsible for improved 
xylose utilization, we re-sequenced the entire genome of the E26 XUS strain and compared 
this sequence to the E26 sequence we described previously (Liu et al. 2015a, 2015b).  
After SNP analysis, we found that only one absolute mutation (S713L) occurred in an 
annotated open reading frame (in YALI0F01562p).  YALI0F01562p is a putative protein 
on the F chromosome that shows similarity to some C6 transcription factors and nitrogen 
regulators by BLAST homology search (Madden 2003) .  Interesting, we did not see this 
same mutation based on Sanger sequencing in the other alternative xylose utilizing strains 
isolated in this work (strains shown in Figure 2-1).  Thus, while potentially interesting, 
this mutation was not a ubiquitously dominant, causative mutation for improving xylose 
utilization. 
Beyond SNPs in the genome, we also observed that many regions of the genome 
have significantly higher reads relative to their neighboring regions.  Moreover, some of 
these regions had mutations in only a fraction of the reads indicating the presence of 
duplication events / repeated elements with the genome during this process.  Specifically, 
we found 28 regions that were duplicated with mutations in their duplicated copies, and 
hundreds with duplications but no mutations. The sizes of the duplicated pieces ranged 
from 100 base pairs to several kilobases.  Due to the inability to fully scaffold most of 
these repeated reads due to their length, it is not possible to exclude the possibility that 
some of the repeated pieces of DNA were inserted into regions related to xylose utilization.  
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Furthermore, it became clear that multiple copies and reads of the XYL1 and XYL2 genes 
were present.  This observation together with the lack of any mutations in the promoter 
regions of these genes would lead to the increase in expression seen in Figure 2-3. 
To validate an increased copy number of XYL1 and XYL2, we performed a qPCR 
assay on genomic DNA for copy number of the XYL1 and XYL2 genes before and after the 
starvation adaptation.  Indeed, we found that the copy number of XYL1 in E26 XUS was 
3.2 fold higher than in E26 XYL1XYL2, and the copy number of XYL2 in E26 XUS was 3.6 
fold higher than in E26 XYL1XYL2 strain (Figure 2-4A).  To further confirm that this 
observation of increased copy number of genes was genuine across all isolated strains, we 
measured the copy number of XYL1 and XYL2 in the other 6 strains that can grow on xylose 
and described in Figure 2-1.  From this analysis, we found that most of these strains have 
at least one gene with more copies than the parental strain (Figure 2-4B).  Furthermore, 
there was a strong correlation between the actual growth on xylose (Figure 2-1) and 
increased copy numbers for both XYL1 and XYL2 (Figure 2-4B). 
As a result, the genome sequencing and copy number assays demonstrates an 
increase in copies of the XYL1 and XYL2 genes that may have been generated through the 
same mechanism as the other repeat elements found within the genome.  This observation 
indicates that the genome of Y. lipolytica may in fact be a rapidly evolving and potentially 
dynamic system at times.  As evidence for this fact, we conjectured that it may be possible 
that during the 216 hour bioreactor fermentation, further genome restructuring may occur 
due to the selection pressure on xylose.  Moreover, we did observe some bioreactor runs 
that were more efficient than others leading to this suspicion.  To confirm this finding, we 
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performed the copy number assay on XYL1 and XYL2 from genomic DNA extracted at the 
end of the bioreactor fermentations from six independent trials.  This analysis did show 
that copy number can vary by up to 3-fold across trials.  Moreover, we saw a distribution 
of both stable genotypes (copy numbers of nearly 3 as seen in the tested E26 XUS strain) 
and further enriching genotypes (further duplicating genotypes leading to higher copy 
number) (Figure 2-4C).  Collectively, these results point both toward the malleability of 
the Yarrowia genome as well as the potential for further improvements to this strain. 
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Figure 2-4: Relative genomic copy numbers of XYL1 and XYL2.  
 
(A) RelativeXYL1 and XYL2 copy number in strain E26 XUS. (B) Relative XYL1 and 
XYL2 copy number in different isolated E26 derived strains as shown in Figure 2-1. (C) 
Relative XYL1 and XYL2 copy number from 192 h samples of different bioreactor 
fermentations are displayed. Genomic copy number of actin gene was used as reference. 
Each data point represents an average value ± 1 standard deviation calculated from the 
results of three biological replicates (A) or three technical replicates (B and C). 
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2.3.5 Evaluation of E26 XUS for xylose-glucose co-utilization fermentation 
After having characterized the E26 XUS strain and identifying the underlying 
genetic factors, we sought to further evaluate its potential in glucose-xylose co-utilization, 
a significant barrier in bio-ethanol production using genetic modified S. cerevisiae (Subtil 
and Boles 2012).  Prior studies have claimed that Y. lipolytica xylose utilizing strains are 
able to co-utilize glucose and xylose at low concentrations (Ryu, Hipp and Trinh 2015).  
Previous work on sugar transporters from Y. lipolytica in our laboratory suggest that they 
are more specific for glucose than xylose when heterologously expressed (Young et al. 
2011, 2014).  To thoroughly test co-utilization properties, we tested our E26 XUS strain 
in YNB + CSM media with 60 g/L glucose and 30 g/L xylose, a concentration and ratio 
that best mimics the hydrolysate produced from corn stover (Dale and Ong 2012).  In 
contrast to previously reported studies, we did not observe any appreciable xylose 
utilization in the presence of 60 g/L glucose (Figure 2-5).  These results align with our 
prior transporter studies suggesting that xylose utilization in Y. lipolytica is inhibited by 
glucose, at a minimum, at least at high concentrations.  However, it was noted that the 
E26 XUS strain grew significantly better than E26 strain in the mixed sugar media with a 
marked improvement in glucose utilization rate.  This observation is indeed promising 
and while flask experiment may not directly reflect behavior in bioreactors, it is worth 
investigating the potential of this strain in glucose in a follow-up experiment. 
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(A) Growth profile of E26 vs. E26 XUS on 60 g/L glucose and 30 g/L xylose. (B) 
Glucose and xylose concentration in the mixed sugar fermentations were measured. Each 
data point represents an average value ± 1 standard deviation calculated from the results 





Work within in this chapter, we established a strain of Y. lipolytica that is able to 
utilize xylose as a sole carbon source for growth, and convert this sugar into intracellular 
lipids.  This result was obtained by first introducing heterologous XYL1 and XYL2 genes 
from S. stipitis into Y. lipolytica and second enabling gene duplication that occurred 
through starvation.  The resulting strain, E26 XUS, was able to grow to OD600 above 100 
in bioreactor fermentations and produced nearly 15 g/L of lipid at a maximum productivity 
of 0.19 g/L/h.  While this strain produced less lipid than observed from similar 
concentrations of glucose (39.1 g/L from glucose (Liu et al. 2015b)), the strain was able to 
support higher growth in glucose/xylose mixed sugar media relative to the parental E26, 
suggesting further interesting features with the genome rearrangements. 
Throughout this experiment, it was clear that increases to the copy number of this 
heterologous pathway led to increased expression and improved phenotype.  However, it 
is important to note that the observed expression level of XYL1 and XYL2 did not directly 
correspond (i.e. 1:1 correlation) to the copy number increase, thus integration loci plays an 
important role.  The integration plasmids used in this study contained 26S ribosomal 
DNA regions flanking the expression cassette.  At first, it was presumed that multiple 26S 
sites in the Y. lipolytica genome were the likely source of these multiple integrations.  
However, TAIL-PCR was unable to confirm that the initial integrations nor the later 
duplicated ones have inserted into 26S regions.  In contrast, we did find evidence of a 
potential hot spot for genomic integration in Y. lipolytica.  Specifically, in PO1f XUS 
strain, at least one copy of XYL1 has integrated into Chromosome C before nucleotide 
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45962, and at least one copy of XYL2 of E26 XUS was also integrated into this same locus. 
It should be noted that none of the original copies in the XYL1XYL2 strain were integrated 
into this spot suggesting that this location may be a hot spot for duplication activity.  
Regardless, this work further provides yet further proof that the efficiency of homologous 
recombination in Y. lipolytica is very low and that short flanking pieces of DNA do not 
result in specific, targeted integration in Y. lipolytica.  
The very existence of multiple duplications (even evolving ones throughout the 
course of a fermentation) suggests that the genome of Y. lipolytica is quite dynamic at 
times.  The observation that starvation of the cell led to high numbers of duplication 
regions (28 with mutations and hundreds without) along with sizes of upward of several 
kilobases demonstrates that the duplication event is not specific to heterologous DNA.  As 
the exact mechanism of the duplication and precise locations of the duplicated pieces are 
still unknown, and it is not clear how vastly altered the overall chromosomal structure of 
Y. lipolytica can become.  Nevertheless, this high adaptability of the Y. lipolytica genome 
can be a great advantage when doing metabolic engineering and strain improvement.  At 
the same time, it could also present challenges for stable industrial production. 
The creation of a xylose utilization phenotype through starvation was possible in 
both the engineered E26 and wild-type PO1f strains.  Thus, it can be concluded that the 
observed duplications were not a product of the engineering and EMS mutagenesis used to 
construct the E26 strain.  As a result, prior attempts at creating xylose utilizing strains 
using 4 and 10 day “adaptation” steps (Tai 2012; Ryu, Hipp and Trinh 2015) may have 
likely led to similar duplications.   
 28 
In this work, we were not able to construct a xylose utilizing strain using the xylose 
isomerase pathway despite success with this enzyme in S. cerevisiae (Lee, Jellison and 
Alper 2012, 2014).  It is unclear what limitations exist for making this pathway functional 
and this enzyme may require mutations for stability.  Future work that can activate this 
pathway would take advantage of the co-factor free nature of the isomerase pathway 
compared to the oxidoreductase pathway (Dulermo et al. 2015). 
Finally, the observed growth kinetics and sugar utilization rates indicated that the 
xylose utilization in the E26 XUS strain was strongly inhibited with conditions of 60g/L 
glucose and 30g/L xylose.  As a result, further work is necessary to remove the inhibition 
by glucose to enable a co-fermentation.  Nevertheless, the resulting titer and yield of lipid 
production from xylose achieved here are appreciable with future promise for improved 
productivity through additional strain engineering.  
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Chapter 3:  Improving Xylose Utilization in Yarrowia lipolytica 
through Metabolic Engineering  
3.1 INTRODUCTION 
Improving the conversion of xylose by the unconventional yeast Yarrowia 
lipolytica has the potential to improve the economics of product production. To this end, 
researchers have attempted to improve sugar utilizing efficiency through metabolic 
engineering. Enabling Y. lipolytica to utilize xylose, the second most abundant sugar in 
biomass hydrolysate, can theoretically improve titer as much as 50% on total biomass 
(Pauly and Keegstra 2008). Results discussed in Chapter 2 demonstrated the ability to 
enable Y. lipolytica to utilize xylose and produce lipids from this xylose (Li and Alper 
2016). In this chapter, several different pathway engineering applications are undertaken 
to further improve Y. lipolytica growth on xylose. First, several genes downstream of 
XYL1 and XYL2 were overexpressed to increase carbon flux downstream. These results 
uncover that overexpressing native XKS drastically improved the growth in xylose 
whereas overexpressing the other four genes in pentose phosphate pathway (PPP) did not 
make a difference. Next, attempts were made to improve growth in xylose by balancing 
cofactors. In previous fermentation runs, xylitol was identified in the end product, which 
indicates that not all of the xylose was utilized fully due to a co-factor imbalance. Two 
approaches were tried to balance the cofactors. However, introducing NADH 
phosphatase or replacing NADPH preferred XYL1 with an NADH preferred XYL1.2 
from Spathaspora passalidarum both did not improve growth on xylose. 
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3.2 RESULTS 
3.2.1 Improving xylose utilization in Y. lipolytica by overexpression of ylXKS and 
pentose phosphate pathway targets 
In prior work, we established a strain of Y. lipolytica capable of converting xylose 
into lipids through the integration of a xylose reductase and xylitol dehydrogenase along 
with a starvation adaptation (Li and Alper 2016). While these strains were suitable to 
utilize xylose, they still suffered from slow conversion. To improve catabolic rates, we 
explored the overexpression of the native xylulose kinase (ylXKS: YALI1F14583g) and 
four native pentose phosphate pathway related genes (ylTAL: YALI1F20914g, ylTKL: 
YALI1E07744g, ylRPE: YALI1C16621g and ylRKI: YALI1B09025g). Constructs 
overexpressing these genes through the use of a strong hybrid promoter (Blazeck et al. 
2011) were integrated into an evolved xylose utilizing strain, PO1f XUS. In an analogous 
manner to S. cerevisiae, ylXKS overexpression greatly improved both growth rate and 
final OD in the presence of xylose (Figure 3-1). This strain reached an OD600 of more 
than 20 in 60 hours whereas the PO1f XUS strain only reached an OD of less than 12 at 
the 156 hour timepoint. The overexpression of ylTAL and ylTKL both individually 
exhibited a slight, but significant, improvement in growth on xylose whereas 
overexpression of ylRKI and ylRPE did not improve growth rate or level. An experiment 
was conducted to stack these targets; however, the results were not significantly distinct 
from just ylXKS alone (Figure 3-2).  
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Figure 3-1: Cell growth of PO1f XUS strain overexpressing genes from pentose 
phosphate pathway 
 
Growth curves of PO1f XUS strain overexpressing native transaldolase (TAL), 
transketolase (TKL), ribose 5-phosphate ketol-isomerase (RKI), ribulose 5-phosphate 
epimerase (RPE) and xylulokinase (XKS) are shown compared with PO1f XUS as 
control. Each data point represents an average ± 1 standard deviation of 3 biological 






Figure 3-2: Cell growth of PO1f XUS overexpressing native transaldolase (TAL), 
transketolase (TKL), or both in addition to overexpressing XKS compared to PO1f XUS 
strain overexpress native XKS only. 
 
Each data point represents an average ± 1 standard deviation of 3 biological replicate 




Next, we tested the overexpression of ylXKS in a high lipid producing, xylose 
utilizing strain (E26 XUS), and saw a similar trend with greatly improved growth on 
xylose (Figure 3-3). As a result, we then chose this particular high lipid xylose strain for 
mating type swap in Chapter 4. The overall function and importance of ylXKS in Y. 
lipolytica has been showed in the literature (Rodriguez et al. 2016). The study conducted 
here further confirms that ylXKS serves as a rate-limiting bottle neck for xylose growth. 
Moreover, the limited impact of other pentose phosphate pathway target overexpressions 
is corroborated by the native propensity for this strain to divert part of its carbon flux into 
the PPP for NADPH generation during lipid production (Wasylenko, Ahn and 
Stephanopoulos 2015a)..  
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Figure 3-3: Cell growth of E26 XUS strain overexpress native XKS compared with E26 
XUS as control. 
 
Each data point represents an average ± 1 standard deviation of 3 biological replicate 
experiments that were grown in parallel. 
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3.2.2 Attempt to balance cofactors in xylose pathway by overexpression of ylYef1 
The xylose pathway includes a xylose reductase (XR) and xylitol dehydrogenase 
(XDH) in most fungi that can utilize xylose (Young, Lee and Alper 2010). The XR and 
XDH we previously introduced into Y. lipolytica was from Scheffersomyces stipitis. This 
XR, also known as XYL1 prefers NADPH as its co-factor and the XDR, known as XYL2 
prefers NAD+ as a cofactor.  There are three native NAD+/NADH kinases identified in 
Y. lipolytica. Among them, only ylYEF1 was identified to improve lipid yield (Qiao et al. 
2015). However, none of these enzymes was measured for in vitro activity. In this study, 
we cloned ylYEF1 into an overexpression cassette and integrated it into PO1f XUS XKS 
strain. However, we were not able to observe an improvement in growth (Figure 3-4) or 
xylose utilization (Figure 3-5), and conversely, saw a slight drop in both. We also 
measure the lipid production for the final time point, and observed no visible difference 
between the two strains (data not shown). 
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Figure 3-4: Cell growth of PO1f XUS ylXKS strain overexpress ylYEF1 compared with 
PO1f XUS ylXKS as control. 
 
 
Each data point represents an average ± 1 standard deviation of 3 biological replicate 
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Figure 3-5: Xylose utilization of PO1f XUS ylXKS strain overexpress ylYEF1 compared 
with PO1f XUS ylXKS as control. 
 
 
Each data point represents an average ± 1 standard deviation of 3 biological replicate 
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3.2.3 Attempt to balance cofactors in xylose pathway by overexpressing spXYL1.2 
Most xylose reductase (XR) prefers NADPH over NADH (Bruinenberg et al. 
1983). However, this preference can be reversed in some organism. Spathaspora 
passalidarum is an organism that grows very well on xylose and is the only organism 
without glucose inhibition on xylose utilization. Sequencing has demonstrated that this 
organism has two XRs. One of these enzymes prefers NADPH over NADH whereas the 
other prefers NADH over NADPH, which will be referred as spXYL1.2 in this chapter 
(Long et al. 2012; Cadete et al. 2016). The NADH preferred spXYL1.2 was expressed 
with strong promotor into the Y. lipolytica PO1f XUS XKS strain in an attempt to further 
improve xylose utilization in Y. lipolytica.  
Since our previous xylose utilization strain has been starved to enable XYL1 and 
XYL2 to have multiple copies in the genome, this strain cannot be used to easily test 
spXYL1.2. Specifically, knocking out all copies of XYL1 in this strain would be very 
hard and reintegrating the new enzyme to have the same copy number of both XYL1 and 
spXYL1.2 is almost impossible. Thus, we rebuilt a strain with one copy of XYL2 and an 
extra copy of ylXKS overexpressed from strong hybrid promoters. Then we integrate one 
copy of ssXYL1 (the original enzyme used to generate the xylose utilizing strain) or 
spXYL1.2 into this strain to test their growths. This experimental design was chosen 
based on another study that showed overexpressing XYL1, XYL2 and XYL3 together 
can enable growth on xylose without starvation. We were able to observe growth with 
both versions of xylose reductase. However, the growth was much less than our starved 
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strain (Figure 3-6). Nevertheless, these strains still serve the purpose of comparing the 
two xylose reductases with different preference of cofactors (Figure 3-7).  
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Figure 3-6: Cell growth of PO1f Xyl2 ylXKS strain overexpress spXyl1.2 compared 
with PO1f Xyl1 Xyl2 ylXKS as control. 
 
Each data point represents an average ± 1 standard deviation of 3 biological replicate 




















Figure 3-7: Xylose usage of PO1f Xyl2 ylXKS strain overexpress spXyl1.2 compared 
with PO1f Xyl1 Xyl2 ylXKS as control. 
 
Each data point represents an average ± 1 standard deviation of 3 biological replicate 
























3.3 DISCUSSION  
We tested seven targets in this chapter, and found only native xylulose kinase 
overexpression can improve xylose utilization. It is interesting that overexpression of the 
four targets in pentose phosphate pathway did not result in significant improvement, 
especially since these targets have been previously been tested in S. cerevisiae and shown 
to improve xylose utilization. Our hypothesis for this difference is that genes in the pentose 
phosphate pathway in Y. lipolytica are already been expressed at very high level 
(Wasylenko, Ahn and Stephanopoulos 2015b). Thus, none of these four enzymes are rate-
limiting bottlenecks for xylose utilization. This hypothesis is supported by a previous study 
showing that Y. lipolytica diverse part of the carbon flux into pentose phosphate pathway 
to generate NADPH for lipid synthesis. Nevertheless, we determined that xylulose kinase 
is the bottleneck for xylose utilization and overexpressing native ylXKS can significantly 
improve xylose utilization. We also observed that overexpression of the native ylXKS not 
only improved cell growth on xylose, but also imparted a boost in cell growth on glucose. 
This similar growth improvement on glucose was not seen without the overexpression of 
XYL1 and XYL2. It is currently unclear what is causing this observed growth rate increase. 
The several attempts to improve growth on xylose by balancing cofactors in Y. 
lipolytica was not successful. We think that the NAD+/NADH kinases ylYef1 may have 
depleted the NADH pool in Y. lipolytica and thus caused a drop in growth on xylose. 
Alternatively, the activity of spXyl1.2 may be too low in this host that the balancing of 
cofactors does not make up for reduced enzyme activity. As mentioned above, Y. lipolytica 
can generate NADPH by divert carbon flux into pentose phosphate pathway. In that case, 
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the xylitol accumulation we observed may not due to co-factor imbalance but from low 
activity of XYL2 compared to XYL1. To test this hypothesis, future study needs to 
introduce better xylitol dehydrogenase into Y. lipolytica to test whether xylitol 




Chapter 4:  Producing biochemicals in Yarrowia lipolytica from 
xylose through a strain mating approach 
4.1 CHAPTER SUMMARY 
Efficient xylose conversion is an essential feature for producing renewable 
biochemical from lignocellulosic hydrolysate. However, rewiring xylose catabolism is 
challenging, especially for unconventional yeasts. In this study, we demonstrate the 
efficacy of a yeast mating approach with Y. lipolytica that can combine a previously 
engineering and evolved xylose phenotype with a metabolite overproduction phenotype. 
Specifically, we mated several engineered Y. lipolytica strains that produce α-linolenic 
acid, riboflavin and triacetic acid lactone with an engineered and adapted xylose utilizing 
strain to obtain three diploid strains that rapidly produce these molecules directly from 
xylose. Specifically, titers of 0.52 g/L ALA, 96.6 mg/L riboflavin and 2.9 g/L TAL 
respectively from were obtained from xylose in flask cultures. This production level was 
generally on par or higher than the parental strain cultivated on glucose. This result 
showcases the first study using strain mating in Y. lipolytica for producing biomolecules 
from xylose, and thus demonstrates the utility of this approach as a routine tool for 
metabolic engineering. 
4.2 INTRODUCTION 
While xylose has long been considered an important carbon source for the 
production of renewable fuels and chemicals (Jeffries 1983; Kwak et al. 2019), enabling 
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full and efficient utilization remains a challenge in the field (Young, Lee and Alper 2010; 
Harner et al. 2015; Jin et al. 2015b; Sànchez Nogué and Karhumaa 2015). The 
underlying challenge is that xylose catabolism is non-native for most commonly explored 
microorganisms (Wang, Shopsis and Schneider 1980; Jeffries and Jin 2004; Jagtap and 
Rao 2018) and thus mismatched with production capacity. To this end, Y. lipolytica is a non-
conventional, oleaginous yeast that can be rewired to produce a wide variety of products 
after metabolic engineering (Liu et al. 2015a, 2015c; Abdel-Mawgoud et al. 2018; 
Spagnuolo et al. 2018), but does not fastidiously utilize xylose (Wagner and Alper 2015). 
In the past few years, several labs have reported on engineered xylose utilization in Y. 
lipolytica, specifically for the production of lipids (Ryu, Hipp and Trinh 2015; Ledesma-
Amaro et al. 2016; Li and Alper 2016; Rodriguez et al. 2016). However, conversion of 
xylose into alternative products has not been fully explored in this host partially due to 
the challenges implicit in genetically engineering Y. lipolytica (Larroude et al. 2018) and 
the reliance upon adaptive evolution as part of an engineering strategy in several cases. 
To address this limitation, we describe a yeast mating approach to combine xylose 
utilization capacity with biochemical overproduction into a diploid strain. 
Strain mating is a traditional genetic approach that has been commonly used in 
both fundamental genetics studies and in industrial breeding programs (Steensels et al. 
2014b). As examples, strain mating has been used breed Saccharomyces cerevisiae for a 
variety of desirable phenotypes including higher tolerance to ethanol, adaptation to cold 
temperatures, the ability to ferment oligosaccharides and the accumulation of more 
diverse flavor profiles (Sanchez, Solodovnikova and Wendland 2012; Steensels et al. 
 46 
2014a, 2014b; Snoek et al. 2015; Gibson et al. 2017; Ogata, Iwashita and Kawada 2017).  
Haploid Y. lipolytica likewise have the ability to mate into diploid cells. However, unlike 
S. cerevisiae which genetically encode two sets of mating loci and possess the ability to 
mating type switch, Y. lipolytica only has a single mating locus and hence does not 
switch mating type. As a result, two mating types of Y. lipolytica exist, type A and type 
B, depending on what is coded in this singular locus (Barth and Gaillardin 1997). Within 
the Y. lipolytica mating locus is two genes: one that controls conjugation and the other 
that controls sporulation (Weber, Kurischko and Barth 1988; Barth 2011). While the 
genetics and physiology of mating have been explored in this host, very little application 
has been proposed and applied for strain breeding. 
Here, we sought to utilize strain mating in Y. lipolytica to combine a xylose 
catabolic phenotype with biochemical overproduction. Specifically, we take a xylose 
utilizing strain (obtained partially via strain adaptation) and convert the mating type from 
type A to type B and then mated this strain with three other type A production strains (for 
α-linolenic acid, riboflavin, and triacetic acid lactone) to generate diploid strains capable 
of producing new metabolites from xylose. The results demonstrate the ability to retain 
both phenotypes from the haploid mated strains (i.e. high production and xylose 
utilization). In fact, production was generally higher from xylose. Collectively, these 
results show that strain mating can be a powerful tool to make diverse products from 
xylose in Y. lipolytica.  
 47 
4.3 RESULTS 
4.3.1 Converting the mating type of the xylose utilizing strain 
The high lipid producing, xylose utilizing strain was engineered from the PO1f 
strain background (Beopoulos et al. 2008; Liu and Alper 2014; Li and Alper 2016), a 
mating type A strain. As this is a popular background host strain, we sought to mate-
switch this singular strain to type B in an effort to serve as a viable mating partner to 
combine xylose utilization with any other type A strain. To do so, we utilized a piggyBac 
transposon system for a marker-less mating type switch (Wagner, Williams and Alper 
2018).  Specifically, Y. lipolytica wild-type MATB1 and MATB2 along with flanking 
DNA was synthesized by IDT and assembled into a singular plasmid together with the 
NAT dominant selection marker using Gibson assembly. The MATA1 and MATA2 
regions was then replaced by the synthesized MATB1-MATB2-NAT construct via a split 
marker homologous recombination method. The NAT marker was flanked by a pair of 
piggyBac ITR sequences to enable excision by an excision-only piggyBac transposase 
mutant (Figure 4-1). Following PCR confirmation of the mating type switch, we used this 
resulting strain (derived from E26 XUS with the additional xylulokinase activity and 
mating type switch) for all subsequent mating studies. This mating type B strain will be 
referred as XUS-B as a short-hand for the rest of this paper.  
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Figure 4-1: Mating type switch of E26 XUS XKS strain. 
 
MATA1 and MATA2 region was first replaced by MATB1 and MATB2 and NAT 
marker with ITR flanking through homologous recombination. And then NAT marker 




4.3.2 Conjugation frequency 
To quantitatively determine the conjugation frequency, we overexpressed far-red 
fluorescent protein mKate in XUS-B strain and mated it with a wild-type PO1f strain 
overexpressing humanized Renilla reniformis-derived GFP (hrGFP). The mated culture 
was quantified by a BD Accuri™ C6 Plus flow cytometer to determine the composition 
of haploid and diploid strains based on fluorescent protein expression (Figure 4-2). From 
this analysis, the conjugation frequency was estimated to be 0.081% within this 
unselected population, which is consistent with previous reports suggesting the frequency 
is 0.04% (Weber, Kurischko and Barth 1988). While this value is congruent with other 
literature values, we noted throughout this experiment that the absolute conjugation 




Figure 4-2: Flow cytometry results of mated culture grow out in unselected media. 
 




4.3.3 Achieving a xylose catabolizing strain overproducing ALA via mating 
Given the oleaginous nature of XUS-B, we first decided to test the efficacy of 
creating a xylose-utilizing, α-linolenic acid producing strain (ALA-A). To do so, we 
chose our previously reported type A strain that produces α-linolenic acid (ALA) 
(Cordova and Alper 2018), a medically important polyunsaturated fatty acid with three 
double bounds (Narisawa et al. 1994; Stark, Crawford and Reifen 2008; Rodriguez-
Leyva et al. 2010). Successful mating (following the protocol describe above with 
selection) resulted in diploid strains that produced ALA. The diploid strain XUS-B x 
ALA-A grows to a higher peak OD in both glucose and xylose (Figure 4-3) than the 
original ALA haploid strain. This mated, diploid strain also produces more total lipid 
when glucose is used as carbon source (1.74 g/L) and slightly less total lipid when xylose 
is the sole carbon source (1.47 g/L) than the original ALA strain produces in glucose 
(1.59 g/L). Within this lipid pool, the mated strain produced nearly 2.5 times more ALA 
(0.61 g/L) on glucose and more than 2 times more ALA (0.52 g/L) on xylose compared to 
the parental haploid strain, ALA-A (0.24 g/L). Percentage-wise, ALA comprised around 
35% of total fatty acids from both glucose and xylose, whereas the haploid strain only 
had 15% of fatty acids as ALA on glucose in this run (Figure 4-4). These results 
demonstrate a more robust diploid strain with benefit realized in both glucose and xylose. 
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Figure 4-3: Cell growth of ALA, XUS and their mated diploid strain. 
 
Growth curves of ALA-A, XUS-B and ALA-A x XUS-B strain flask experiment were 
shown with glucose or xylose as carbon source. Growth curve of ALA-A grow in xylose 
media is not shown due to lack of growth. Each data point represents an average ± 1 




Figure 4-4: Growth rate, sugar consumption and ALA distribution of ALA-A. XUS-B 




a. Maximum growth rate; b. sugar consumption and c. lipid distribution were measured at 
240 hours of flask fermentation. Each data point represents an average ± 1 standard 
deviation of 4 biological replicate experiments that were grown in parallel.  
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Next, we evaluated ALA production of this diploid strain in 1.7 L bioreactors 
with xylose as the sole carbon source. To do so, we mimicked our previously-published 
bioreactor run and substituted xylose instead at the same concentration as glucose had 
been used. Similar to the performance of the parental strain on glucose, the diploid strain 
reached an optical density higher than 50 while grown on xylose. This reactor supported 
a dry cell weight of over 15 g/L, of which almost 6 g/L was lipid (Figure 4-5a). The final 
titer of ALA reached 1.42 g/L, equivalent to 25.3% of total lipid content (Figure 4-5b). 
While this number is lower than the 35.6% achieved in a flask setting, it is significantly 
higher than the 17% seen in the haploid strain grown on glucose under this same 
bioreactor setting. By the end of the run, a residual content of nearly 40 g/L of xylose 
remained and this strain exhibited a substantial decrease in oleic acid (C18:1) percentage 
(Figure 4-6).  
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Figure 4-5: Bioreactor fermentation of ALA-A x XUS-B strain. 
a.  
b.  
a. Dry cell weight, total lipid and xylose concentration were determined from duplicate 
analysis of biological replicates. b. ALA content and ALA percentage of total lipid were 
determined from duplicate analysis of biological replicates. Each data point represents an 
average ± 1 standard deviation of 2 biological replicate experiments that were grown in 
parallel. 
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Figure 4-6: Lipid distribution at 240 hours in flask experiment. 
 
Lipid distribution of ALA in xylose media is not shown due to lack of growth. Each data 
point represents an average ± 1 standard deviation of 4 biological replicate experiments 
that were grown in parallel. 
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The performance of this diploid ALA strain obtained by crossing ALA-A x XUS-
B achieved high content of ALA approaching, if not ever so slightly exceeding, the 33% 
threshold suggestive of multiple positioning on the triglyceride backbone. To follow up 
on this result, we measured ALA production in xylose-containing rich medium 
(YP+xylose) and determined that ALA actually exceeded 50%, indicating that xylose 
utilization (in complex media) can enable ALA to be substituted on multiple backbone 
positions (Figure 4-7). As a comparison, the most common source of dietary 
supplemented ALA is from flaxseed oil, and the ALA percentage in flaxseed oil is 
around 58% (Bozan and Temelli 2008). The ALA content in our diploid Y. lipolytica is 
very close to flaxseed oil. Furthermore, the ALA percentage within the bioreactor 
increases after total lipid has stabilized, thus indicating the potential that the desaturase 
enzyme can function not only on free fatty acid but also on fatty acid chains on TAG.  
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Figure 4-7: Lipid distribution of ALA-A x XUS-B strain grown in YPX media. 
 










4.3.4 Mating XUS-B with a riboflavin producing strain 
Next, we sought to mate the XUS-B strain with a previously reported riboflavin 
(vitamin B2)  producing strain (Wagner et al. 2018). Riboflavin is a dietary vitamin 
commonly produced by microorganisms industrially (Schwechheimer et al. 2016; 
Revuelta et al. 2017). Mating the riboflavin producing strain with a xylose utilizing strain 
has the benefit of increasing flux through the pentose phosphate pathway so that it could 
optimally feed into riboflavin production (Schwechheimer et al. 2016).  
To create a xylose-catabolizing, riboflavin producing strain, we mated the XUS-B 
strain with a metabolic engineered riboflavin production strain termed RIB-A (Wagner et 
al. 2018). This haploid, parental RIB-A strain had already undergone multiple rounds of 
mutagenesis and selection to enable more than 85 mg/L extracellular riboflavin in defined 
medium with 40 g/L initial glucose at 400 hours (Figure 4-8c). The mated diploid strain 
of RIB-A x XUS-B grow on xylose and produced 102 mg/L riboflavin from glucose, and 
97 mg/L from xylose, both of which exceed the value from the parental RIB-A strain 
grown on glucose (Figure 4-8 a-c). In contrast, the other parental strain (XUS-B) only 




Figure 4-8: Growth rate, sugar consumption and riboflavin production of RIB-A, XUS-B 





a. Maximum growth rate; b. sugar consumption at 400 hours; c. riboflavin concentration 
at 400 hours. Each data point represents an average ± 1 standard deviation of 3 biological 
replicate experiments that were grown in parallel. 
 61 
4.3.5 Mating with TAL strain 
As a final demonstration, we chose to create a xylose-utilizing polyketide strain. 
Polyketides are an interesting class of secondary metabolites with great potential 
(Robinson 1991; Lim, Go and Yew 2016; Palmer and Alper 2019). For this study, we 
chose to mate our XUS-B strain with a rewired strain of Y. lipolytica engineered to 
overproduce substantial amounts of triacetic acid lactone (TAL) (Markham et al. 2018). 
Here, the mating type A TAL production strain (TAL-A) when mated with XUS-B was 
able to achieve high growth, reaching OD levels of 24.9 and 20.9 on glucose and xylose 
compared with a value of 10.2 for the parental TAL producing strain (TAL-A). In similar 
fashion to the riboflavin strain, this diploid strain more rapidly and completely consumed 
sugars during the flask fermentation (Figure 4-9b) when compared with the parental 
TAL-A strain. Whereas the TAL production was faster initially from the TAL-A strain, 
final fermentation analysis shows that the diploid strain produced 2.6 and 2.9 g/L TAL 
from glucose and xylose, respectively compared with the 2.3 g/L produced from the 
haploid strain (Figure 4-9c). Finally, we measured lipid content in the cells and saw that 
only 0.23 g/L of lipid was produced in the diploid strain, thus this imparted phenotype 
did not strongly adversely impact TAL production. 
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Figure 4-9: Growth rate, sugar consumption and TAL production of TAL-A, XUS-B and 






a. Maximum growth rate; b. sugar consumption at 168 hours; c. TAL concentration at 168 
hours. Each data point represents an average ± 1 standard deviation of 4 biological replicate 
experiments conducted from separate mating events that were grown in parallel. 
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4.4 DISCUSSION 
This study demonstrates the feasibility of rapidly and efficiently enabling xylose 
catabolism in previously-engineered Y. lipolytica strains. Remarkably, the diploid strains 
could sustain production from xylose that were on par or higher than levels from glucose. 
In the end, we demonstrated production of 0.52 g/L ALA, 96.7 mg/L riboflavin and 2.9 
g/L from xylose respectively. The parity of glucose- and xylose-based production 
confirms the strong carbon flux through the PPP in this organism.  
Overall, we observed that diploids tended to be more robust with respect to 
overall growth than haploids—a phenomenon seen in S. cerevisiae as well (Galitski et al. 
1999). Specifically, we found that overexpression of the native ylXKS not only improved 
cell growth on xylose, but also imparted a boost in cell growth on glucose. This similar 
growth improvement on glucose was not seen without the overexpression of XYL1 and 
XYL2. While it is currently unclear what is causing this observed growth rate increase, it 
can be seen in haploid and diploid strains with this genotype. In fact, the poorer growth 
seen in all three of the haploid production strains was revived by the mating (Figure 4-4, 
4-8a-b, 4-9a-b). Specifically, all diploid strains more thoroughly used sugars in these 
fermentations (with a substantial amount going to biomass). We posit that the increased 
growth rates are also advantageous in the stability of the strains. In particular, diploid 
yeast can return to haploid form through sporulation. For Y. lipolytica, sporulation has 
been reported to be triggered by citrate sporulation medium or commercial V8 juice 
(Gaillardin, Charoy and Heslot 1973; Barth and Weber 1985), although sporulation has 
also been observed in the YM mating media itself. In previous reports, sporulated culture 
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will have a brownish color, which we did not observe. Likewise, attempts to sporulate 
these strains were not successful using techniques reported in the literature. Prior reports 
also suggest that Y. lipolytica can go through parasexual cycle to convert from diploid to 
haploid (Kurisciiko 1986). To evaluate this phenomena, we isolated colonies after 
fermentations here and did not find any haploid cells emerging in the culture. These 
findings suggest that the strong stability (and robust growth) of these mated strains are 
attractive for industrial processes. To further test the robustness of the mating approach, 
the TAL strain mating event and resulting flask fermentation was conducted using 
replicates separate mating events. The resulting production was very consistent across 
these separately mated diploid strains, another positive marker for strain 
robustness/stability. 
Each of the diploid strains isolated in this work took advantage of xylose 
utilization and antibiotic resistance already in the type A strain. It is possible that 
alternative uses of this technology may not have an easily selectable genotype. In such 
cases, due to the low efficiency of mating, it would be necessary to establish a rapid 
method for identifying metabolite production. It is likely that further improvements to the 
mating process itself could further increase efficiency. Finally, the type B strain used in 
this work was a high lipid producer. Such a phenotype is not always compatible with the 
end goal (as was the case with TAL production as these lipids divert flux away from the 
TAL pathway). As a result, future extensions of this work could create a type B strain 
that is not a lipid-hyperproducer. 
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This study demonstrates the efficacy of Y. lipolytica mating for strain engineering 
efforts and expanding the product portfolio from xylose. This approach allows for a far 
quicker approach to strain engineering than importing the xylose catabolic pathway and 
undergoing strain adaptation. Thus, mating with pre-optimized strains can be beneficial 
in this host. 
4.5 CONCLUSION 
In summary, this study shows that Y. lipolytica mating can be used as a powerful 
tool for strain engineering in this host. The mated strains reached titers of 0.52 g/L ALA, 
96.6 mg/L riboflavin or 2.9 g/L TAL respectively from xylose in flask conditions. These 
titers and resulting growth and sugar consumption rates indicates that diploid strains as 
generated here are quite fit and robust. The use of a mating approach in Y. lipolytica can 




Chapter 5: Enabling glucose/xylose co-transport in yeast through the 
directed evolution of a sugar transporter22 
5.1 CHAPTER SUMMARY 
The capacity to co-transport glucose and xylose into yeast has remained a 
technical challenge in the field.  While significant efforts have been made in transporter 
engineering to increase xylose transport rates, glucose-based inhibition still limit most of 
these transporters.  To address this issue, we further engineer sugar transporter proteins 
to remove glucose inhibition and enable glucose/xylose co-transport.  Specifically, we 
start with our previously derived CiGXS1 FIM mutant strain and subjugate it to several 
rounds of mutagenesis and selection in a hexose metabolism null strain.  Through this 
effort, we identify several mutations including N326H, a truncation in the C-terminal tail, 
I171F, and M40V as additionally dominant for reducing glucose inhibition.  The 
resulting transporter shows substantially improved xylose transport rates in the presence 
of high quantities of glucose including up to 70 g/L glucose.  Moreover, the resulting 
transporter enables co-utilization of glucose and xylose with glucose rates on par with a 
wild-type transporter and xylose rates exceeding that of glucose.  These results 
demonstrate that major facilitator superfamily hexose transporters can be rewired into 
                                                 
2 Content in this chapter adapted from a previously authored publication written by HL. HL equally 
contributed to the contributed to experiments, analyses and writing of the manuscript.  
Haibo Li, Olivia Schmitz and Hal S. Alper, 2016. Enabling glucose/xylose co-transport in yeast through the 
directed evolution of a sugar transporter. Applied Microbiology and Biotechnology 100(23):10215-10223. 
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glucose-xylose co-transporters without functional inhibition by either substrate.  These 
results enhance the potential of using lignocellulosic biomass as a feedstock for yeast. 
5.2 INTRODUCTION 
First generation biofuels and biochemicals derived from food crops have 
significant economic and societal drawbacks (Naik et al. 2010).  As a result, the use of 
second generation biofuels produced from lignocellulosic biomass has been studied 
extensively (Lynd 1996; Naik et al. 2010; Dale and Ong 2012).  Depending on the 
organism used, several challenges exist with respect to the monosaccharide profile 
resulting from hydrolysate (Kumar et al. 2009; Chiaramonti et al. 2012; Brethauer and 
Studer 2015; Marriott et al. 2015).  Of high importance for the common bioethanol 
producing yeast Saccharomyces cerevisiae (Van Vleet and Jeffries 2009), lignocellulose 
hydrolysate is comprised of not just glucose, but also xylose which can vary from 5% to 
35% of total sugar content depending on the biomass source (Gírio et al. 2010).  Since 
wild-type S. cerevisiae strains are unable to natively catabolize xylose (Jeffries and Jin 
2004; Sànchez Nogué and Karhumaa 2015), significant metabolic and evolutionary 
engineering strategies have been applied to improve utilization (Jeffries 1983; Kuyper et 
al. 2003; Lee et al. 2012, 2014; Scalcinati et al. 2012).  As a result, xylose catabolic 
rates have been improved in recent years using a variety of strategies (Jeffries and Jin 
2004; Salusjärvi et al. 2006; Young, Lee and Alper 2010; Scalcinati et al. 2012; Shen et 
al. 2012; Kim et al. 2013; Parreiras et al. 2014; Harner et al. 2015; Bamba, Hasunuma 
and Kondo 2016). 
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Despite success in improving xylose catabolic rates, S. cerevisiae still suffers 
from efficient co-utilization of glucose and xylose due to a strong native preference for 
glucose as the primary carbon source (Matsushika et al. 2009; Young, Lee and Alper 
2010).  In a typical fermentation, xylose is utilized only when glucose is completely 
consumed, which leads to additional decreases in efficiency due to higher concentrations 
of ethanol and acetic acid that inhibit xylose catabolic rates (Klinke, Thomsen and Ahring 
2004; Demeke et al. 2013).  As a result, a renewed interest has been placed on enabling 
co-utilization of these primary carbon sources in lignocellulosic biomass.  
A number of previous studies suggest that a primary factor driving glucose 
preference originates at the sugar transporter proteins in the cell membrane (Salusjärvi et 
al. 2006, 2008; Subtil and Boles 2012).  Specifically, while some hexose transporters 
are able to facilitate xylose transport, they are typically strongly inhibited by glucose 
even at low concentrations (Sedlak and Ho 2004; Young et al. 2011).  Several groups 
have studied the potential to engineer such transporter proteins for improved rates of 
xylose transport (Farwick et al. 2014b; Nijland et al. 2014; Shin et al. 2015; Wang, Yu 
and Zhao 2015).  Previously, our lab identified a sequence motif in symporters that can 
rewire glucose transporters (such as the Candida intermedia glucose-xylose symporter, 
CiGXS1 (Leandro, Gonçalves and Spencer-Martins 2006)) into a xylose exclusive 
transporter (Young et al. 2012, 2014).  However, these transporters were still typically 
inhibited by glucose (esp. at relevant concentrations in liquid culture) and thus were not 
fully sufficient for co-utilization applications. 
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In this study, we further engineer sugar transporter proteins to remove glucose 
inhibition and enable glucose/xylose co-transport.  Specifically, we start with our 
previously derived CiGXS1 FIM mutant strain and subjugate it to several rounds of 
mutagenesis and selection.  This selection took place in a mutant strain of yeast devoid 
of all glucose transporter proteins and also containing deletion in key hexokinase 
enzymes.  As a result, it was possible to use glucose as an “inhibitor” during the directed 
evolution process. After several rounds of evolution, we identify a glucose/xylose co-
transporter that can tolerate high glucose concentration and can co-transport both sugars 
at equal concentrations with a preference for xylose.  In doing so, this engineered 
transporter further enables the capacity for co-fermentation of lignocellulose derived 
sugars. 
5.3 RESULTS  
5.3.1 Constructing a platform screening strain for reduced inhibition 
In previously work, we identified that a specific sequence (namely V38F L39I 
F40M) within the variable region of the G-G/F-XXX-G motif of transporters like 
CiGXS1 can attenuate glucose transport without compromising xylose transport capacity 
(Young et al. 2014).  However, xylose transport was still highly inhibited by glucose for 
this CiGXS1 FIM transporter and similarly designed transporters.  Therefore, we sought 
to reduce the glucose inhibition here through several rounds of directed evolution.  To 
do so, it was necessary to create a screening strain that could enable selection of xylose 
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transporters that were uninhibited by glucose.  Specifically, we started with the 
EBY.VW4000 strain of S. cerevisiae that has 20 deletions to remove all hexose (and 
hence pentose) sugar transport (Wieczorke et al. 1999).  This host was used in our 
previous work to select for xylose transporter function and evolution (Young et al. 2014). 
To establish a growth-based screen for transporters uninhibited by glucose, it was 
necessary to inactivate glucose metabolism in this host strain.  To do so, we deleted key 
hexokinase steps in this background to create a hxk1, hxk2, and glk1 null strain, in similar 
fashion to a recent report (Farwick et al. 2014b).  Next, xylose utilization genes XYL1 
and XYL2 from Scheffersomyces stipitis as well as GAL2 were cloned onto plasmids and 
transformed to create the strain ETKXG.  This resulting strain was shown to be able to 
grow on xylose and galactose, but not glucose or maltose. As a result, this platform strain 
is capable of being utilized in growth-based selections for transporters that enable xylose 
transport in the presence of increasing concentrations of glucose.  The degree of 
inhibition can be selected by controlling the concentration of glucose used during the 
evolution.  Thus, this strain was used for mutant selection throughout this study. The 
design and selection process is illustrated in Figure 5-1. 
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Figure 5-1: Design strategy of library construction and selection. 
 
Mutant transporters were constructed by error-prone PCR and tested in hexokinase null 
strain (ETKXG). Libraries derived in rounds 1 through 3 were selected on plates with 
increasing glucose concentration. Libraries in the 4th round of selection were subcultured 
in flasks. Initially identified mutants were further tested in test tube fermentation and the 
best mutants were sequenced and used as the template for the next round of mutagenesis. 
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5.3.2 N326H and T170N were identified to reduce glucose inhibition in a first round 
of selection 
To reduce the glucose inhibition present in the CiGXS1 FIM transporter, we 
created error prone-PCR based libraries of this transporter protein followed by selection 
in the strain described above.  In this first round of selection, yeast cells were selected 
on plates containing 20 g/L glucose and 20 g/L xylose.  Such a concentration imposed a 
high selection pressure on the library and resulted in few recovered colonies.  A total of 
eight mutants were isolated during this first round that showed reduced inhibition to 
glucose than the starting transporter, CiGXS1 FIM.  Among these eight mutant strains, 
half had mutations to residue N326 and the remaining half had mutations to T170.  For 
the transporters showing mutations at N326, three were changed to histidine and the other 
to serine.  We observed that the histidine mutation had a more reduced inhibition than 
the serine mutation.  All of the mutations to residue 170 changed the threonine to an 
asparagine.  A corresponding mutation has been identified in gal2, hxt5, hxt7, hxt11 and 
hxt36  (Farwick et al. 2014b; Nijland et al. 2014; Shin et al. 2015; Reider Apel et al. 
2016). CiGXS1 FIM N326H mutant (CiGXS1 FIMH) was less inhibited by glucose than 
T170N (CiGXS1 FIMN) (Figure 5-2).  The entire strain selection process is shown 
depicted in Figure 5-3, starting from strain CiGXS1 FIM with level of glucose inhibition 
plotted across the y-axis. Table 5-1 lists all of the positive mutations found during each 
round of selection.   
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Figure 5-2: Growth curve of ETKXG expressing CiGXS1 FIMH, FIMN and FIMNH 
compared to CiGXS1 WT and FIM. 
 
 
Each data point represents an average value ±1 standard deviation calculated from the 
results of 6 biological replicates. 
  
 74 
Figure 5-3: Phylogeny of mutant transporter strains identified in this study. 
 
Key mutations identified across the evolutionary trajectory explored here are shown. 
Arrows between boxes indicate the evolutionary trajectories taken in this work. The 
placement of boxes aligns with the 48-h glucose inhibition level in 40 g/L glucose and 20 
g/L xylose media, with mutations on the top demonstrating more inhibition by glucose 
than those on the bottom. 
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Table 5-1. Positive mutations identified during the all four rounds of mutagenesis. A 
table cataloguing the mutations identified in this study is provided. 
 
  Parental 
Strain 
Mutations Silent mutations 
First  FIM N326H   
round   N326H   
    L196F, N326H, M345T V29V, L247L 
    D70V, T170N, E231V, K275E R193R, H277H 
    T170N A197A, N455N 
    T170N   
    N326S, V504M S177S, L201L 
    T170N T284T 
Second  FIMH T361S   
round   T361A, F500V   
    C89W, T361A, A366S, A431V, D439G   
    V377I   
    I27F, Q507*   
    F174L   
    F388V   
    A462T   
    S329F L213L 
    T170N, H326N, S368T, E502*   
    F67Y L57L 
    V138I, K181G S163S 
    L175F   
    A462T, D509G   
    L175F, N370I   
    F174L   
    T354S I205I 
  
 
K511E   




Table 5-1 continued. Positive mutations identified during the all four rounds of 
mutagenesis. A table cataloguing the mutations identified in this study is provided. 
 
Third  FIMH497 I171F   
round   I205V, T284I S72S, P240P 
    I362F S72S, P240P 
    L108I   
    K440Q Y55Y, S222S 
    E17V, V132I, L407M C128C, V271V, 
G328G, L340L, 
L346L, L423L 
    I171N, T187S   
    G341D   
    V400I, T409S T170T, A387A 
    F385Y, T428I   
    V377I N112N 
    H185N, E258D   
    K228E L79L, L236L 
    A20P, L407F   
    V377I N112N 
    M353I, G452S I157I, P406P 
    S276P D242D 
    Q226H   
Fourth 
round 





Since two dominant mutations were identified in this first round, we sought to 
combine these mutations to test for additive phenotype effects.  Specifically, we 
constructed a double mutant transporter CiGXS1 FIMNH with both T170N and N326H 
mutations.  The double mutant FIMNH is less inhibited by glucose than FIMN alone, 
however, it is more inhibited than just FIMH alone.  Finally, the N326H mutation 
corresponds to a similar residue modification found in a recent report (Farwick et al. 
2014b).  Specifically, this recent report demonstrates that changing asparagine 376/370 
to phenylalanine for gal2 and hxt7 resulted in xylose transporters with decreased glucose 
inhibition (Farwick et al. 2014b).  The mutation found in this study (N326H) was 
compared with the N326F suggested by the previous study.  By doing so, we 
demonstrate that for CiGXS1, N326H is less inhibited by glucose than N326F (Figure 5-
4).  With this novel mutation validated and tested against prior reports, we sought to 
further reduce glucose inhibition by using CiGXS1 FIMH as a template for a second 
round of mutagenesis and selection.   
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Figure 5-4: Growth curve of ETKXG expressing CiGXS1 N326H and N326F compared 
to WT CiGXS1. 
 
Each data point represents an average value ±1 standard deviation calculated from the 
results of 6 biological replicates.  
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5.3.3 A truncation in the transporter C-terminus further reduces glucose inhibition 
Following a similar strategy as outlined above, a new mutant library was 
generated using CiGXS1 FIMH as a template and was selected on enhanced glucose 
conditions of 40 g/L glucose and 20 g/L xylose plates.  After this selection, a total of 19 
mutants were isolated that exhibited reduced glucose inhibition over FIMH (Figure 5-3, 
Table 5-1).  Once again, a dominant mutation pattern arose.  Specifically, six of the 
mutants were found to have mutations in the C-terminal tail of the transporter with three 
of these resulting in a truncated protein due to a stop codon.  This result strongly 
suggested that a truncation of the C-terminal tail could decrease glucose inhibition.   
To further test this hypothesis and more systematically find an optimal truncation 
locus, we created a truncation library consisting of seven different truncations on the C-
terminal tail of FIMH.  Specifically, residue 467, 477, 487, 497, 502 and 507 were 
replaced with stop codons.  Figure 5-5 shows the growth rate for CiGXS1 FIMH 
truncation mutants growing in 50 mL flasks with 40 g/L glucose and 20 g/L xylose 
relative to the growth of the full-length, 523 amino acid transporter.  These results 
illustrated that a truncation at residue 497 yielded a transporter with the least degree of 
inhibition in the presence of glucose.  This mutant was termed CiGXS1 FIMH497* and 
served as a template for the next round of mutagenesis.  To test the generic nature of 
these findings, we created a similar truncation series in the CiGXS1 FIMN background 
and once again found position 497 as being optimal for reduced inhibition (Figure 5-6).  
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Figure 5-5: Relative growth rate of ETKXG strain expressing CiGXS1 FIMH with 




Filled squares represent mutants with early termination. The empty square represents the 
original, full-length transporter. Each data point represents an average value ±1 standard 
deviation calculated from the results of four biological replicates.  
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Filled squares represent mutants with early termination. Empty square represents original 
C-terminus tail length. Each data point represents an average value ±1 standard deviation 
calculated from the results of 4 biological replicates.  
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5.3.4 Two additional mutations (I171F and M40V reversion) further reduce glucose 
inhibition 
Finally, we conduct two additional rounds of mutagenesis and selection to further 
reduce glucose inhibition.  First, the CiGXS1 FIMH497* truncation mutant identified 
above was used as the template for the third round of mutation and selection.  This 
library was selected on 60 g/L glucose and 20 g/L xylose and resulted in 18 mutations 
demonstrated reduced inhibition (Table 5-1).  While no multiple occurrences of 
mutations were observed in this round, the most improved phenotype resulted from the 
mutation I171F.  It is interesting to note that the I171 residue is adjacent to the T170 
residue identified in the first round of mutation.  Moreover, while N326H and T170N 
did not have an additive effect (Figure 5-3), the N326H and I171F combination is better 
than N326H alone.    
The resulting mutant, CiGXS1 FIMFH497* was then used as a template for a 
final round of mutagenesis and enrichment on 60 g/L glucose and 20 g/L xylose in liquid 
culture with three serial subcultures.  In the end, we observed a singular mutation in the 
selected population.  Interesting, the mutation was on M40 where methionine was 
converted to valine.  This mutation belongs to the G-G/F-XXX-G motif that led to the 
starter transporter for this study (Young et al. 2014).  This reversion of methionine to 
valine allowed for a restoration of glucose transport, but retained the lack of inhibition 
from glucose. 
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5.3.5 Collective comparison of xylose transporters demonstrates a reduction of 
glucose inhibition 
Figure 5-7 illustrates the overall mutations found across all rounds of mutagenesis 
and selection leading to the FIVFH497* transporter mutant.  Each of the main mutations 
across this evolutionary trajectory were cultured in a deep well fermentation experiment 
simultaneously with 20 g/L xylose and varying amounts of glucose ranging from 0 g/L to 
70 g/L.  Figure 5-8 highlights the cell growth after 168 hours as a function of glucose 
concentration.  This data clearly illustrates that as each round of evolution progressed, 
significant improvements were achieved in reducing overall glucose inhibition.  Figure 
5-9 shows a similar trend with respect to the absolute growth rate of the culture.  This 
glucose inhibition level (as calculated by growth rate in the first 48 hours in 40 g/L 
xylose and 20 g/L glucose media) was used as the basis for ordering and spacing the 
mutations on Figure 5-3.  Moreover, it is important to note that in addition to the 
reduced glucose inhibition, these transporters exhibited improved xylose transport rates 
(as highlighted by the growth in 0 g/L of glucose).  This data demonstrates that CiGXS1 
FIVFH497* is a strong xylose transporter with significantly attenuated glucose inhibition 
and retained xylose rates. 
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Figure 5-7: Predicted sequence–structure of CiGXS1 FIVFH497*. 
 
Mutations identified in this study are colored in red, mutations established by our 
previous studies are colored in yellow. The optimized C-terminal truncation site is shown 
with red line. The truncated C-terminus tail region is shown in grey. Transmembrane 
helix domains, helix tail domains and loop structures are predicted by HMMTOP with the 
extracellular region shown on top and cytosol shown below. 
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Deep well plate fermentations were conducted with all strains. OD600 was taken at 168 h 
of fermentation. For this study, 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, and 70 g/L glucose 
was used along with 20 g/L xylose in all cases. Each data point represents an average 




Figure 5-9: Relative growth rate of ETKXG expressing CiGXS1 mutants. 
 
Deep well plate fermentations were conducted with all strains. OD600 was taken at 168 
hours of fermentation. For this study, 0 g/L, 5 g/L, 10 g/L, 15 g/L, 20 g/L, 25 g/L, 30 g/L, 
35 g/L, 40 g/L, 50 g/L, 60 g/L, and 70 g/L glucose was used along with 20 g/L xylose in 
all cases. Each data point represents an average value ±1 standard deviation calculated 
from the results of 4 biological replicates. 
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5.3.6 CiGXS1 FIVFH497* enables yeast to co-transport glucose and xylose  
Owing to the final mutation in this selection process, it was possible that the 
CiGXS1 FIVFH497* could be a potent transporter that enables co-utilization of sugars.  
To test for such co-utilization, the parental EWV4000 strain outfitted with the XYL1 and 
XYL2 genes from S. stipitis were transformed with CiGXS1 WT, FIM and FIVFH497* 
and grown in a culture containing 10 g/L glucose and 10 g/L xylose.  Sugar 
concentrations were monitored throughout the flask fermentation.  Figure 5-10a 
demonstrates that the wild-type transporter was able to transport glucose to a point and 
xylose utilization was completely inhibited.  Figure 5-10b highlights our prior results in 
which the CiGXS1 FIM is no longer able to transport glucose, but xylose transport is 
inhibited by the presence of glucose.  Finally, the CiGXS1 FIVFH497* was tested and 
Figure 5-10c shows that this transporter mutant enables co-utilization of both sugars.  
The glucose transport rate observed here is on par with the rate observed in the wild-type 
transporter and the xylose transport rate exceeds that of the glucose transporter rate.  
This observed ability to transport xylose at high efficiency while maintaining the ability 
to transport glucose makes this transporter a superior candidate for co-fermentation 
applications.  Collectively, these results demonstrate the complete rewiring of a 
predominantly glucose symporter into xylose/glucose co-transporter. 
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Figure 5-10: Glucose and xylose cofermentation. 
 
 
EBY.VW4000 expressing CiGXS1 WT (4a), FIM (4b), and FIVFH497* (4c) were grown 
in 10 g/L glucose and 10 g/L xylose media in shake flask. Both glucose and xylose 
concentrations were measured at various times in the fermentation. Each data point 





Co-utilization of glucose and xylose (at relevant substrate concentrations in liquid 
culture) has been an ultimate goal in the field for S. cerevisiae.  However, the absence of 
a strong transporter capable of enabling this trait has complicated the matter.  
Nonetheless, over the past few years, significant work complements the study here by 
identifying alternative mutations that influence sugar transport rate and selectivity. 
Several of the mutational hot spots identified in this study parallel similar regions 
in S. cerevisiae transporters.  For example, prior research has suggested the importance 
of an arginine residue on transmembrane domain (TMD) 8 and a tryptophan residue on 
TMD 5 for xylose uptake (Farwick et al. 2014b; Nijland et al. 2014; Shin et al. 2015).  
Here, we demonstrate that similar regions on the C. intermedia transporter are likewise 
essential.  Thus, these key residues may be important harbingers of function when 
performing bioprospecting screens.  However, the exact residue composition seems to 
be inconsistent across transporters.  It was interesting to observe here that the N326H / 
T170N double mutant performed worse than the N326H single mutant yet the I171 
mutation was additive with N326H.  Likewise, the N326H mutant performed better than 
the phenylalanine mutation suggested in literature.  Thus, it is likely that the specific 
amino acid composition in these sites will need to be optimized more globally with the 
transporter of interest.  Certainly, a more relevant crystal structure model can help 
elucidate these differences further. 
A unique finding in this work was the identification of a truncated C-terminal 
transporter tail which resulted in a decreased glucose inhibition.  The current best model 
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for a yeast transporter protein comes from the crystal structure of the E. coli xylose 
transporter, XylE (Fedorova et al. 2012).  The XylE transporter however, does not have 
a long C terminus tail like most yeast hexose/pentose transporters.  Given the 
improvement we see in this work by truncating this tail, we hypothesize two potential 
functions for this tail region that can be further investigated in future work.  First, it is 
possible that the C-terminal tail functions as an auto-inhibitory gate that typically 
responds to glucose.  Thus, the removal of this tail allows for xylose to be transported at 
a higher rate.  Second, it is possible that the lysine residues within the C-terminal tail 
can be ubiquinated thus leading to transporter degradation.  In this mechanism, 
removing the tail allows for the enhancement of transporter half-life and/or membrane 
localization traits, thus resulting in improved cell growth and sugar transport.  
Moreover, the enhancements seen in glucose inhibition may be due to changing the next 
number of active transporters on the membrane surface.  While this is an appealing 
regulatory hypothesis, we should note that residue 491 and 489 are both lysine residues, 
but truncations that terminates at A487 grew worse than truncations that terminates at 
K497.  Nevertheless, since the C terminus tail of CiGXS1 does not align well with other 
commonly studied transporters, it is not clear how universal such truncations will be for 
reducing glucose inhibition.  Certainly this study warrants future experiments focused 
on the function of the C-terminal tail of other major facilitator superfamily transporters.  
Regardless, the basic notion that XylE can transport xylose without glucose inhibition 
with a much shorter C-terminus tail (27 amino acids) compared to yeast hexose 
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transporters (55 amino acids for CiGXS1 WT) suggests that the length and composition 
of the C-terminal tail may play a role in substrate preference. 
Finally, the importance of the G-G/F-XXX-G motif has recently been confirmed 
in other experiments using the Hxt7 transporter (Reider Apel et al. 2016). The third 
variable residue (F40 in CiGXS1 and F79 in Hxt7) are clearly related to xylose uptake. 
Young et al. first discovered the F40V mutation and found that F40M mutation would 
completely eliminate glucose transport.  Thus, it is not surprising that we discovered a 
change in this residue in our final round of mutagenesis moving from methionine to 
valine.  The resulting transporter CiGXS1 FIVFH497* is able to transport glucose at the 
WT level while transporting xylose at even higher rate. At 70 g/L glucose, xylose 
transport was still observed, a feat that has not been reported with any other yeast 
transporter to date.  These characteristics demonstrate the potential of this transporter 
for co-utilization applications.  Further investigations are certainly warranted (and 
ongoing) for importing this transporter into a more industrially adequate strain other than 
EBY.VW4000 that has undergone significant chromosomal rearrangement that hamper 
full potential in complex fermentations (Solis-Escalante et al. 2015).  Nevertheless, the 
results depicted in this work show strong co-utilization properties that can be tested in 
other strain.  Moreover, this result demonstrate that hexose transporters (in particular, 
symporters) belonging to the major facilitator superfamily can be rewired to be both 
xylose exclusive and glucose-xylose co-transporters without inhibition by either 
substrate.  Thus, this work addresses a remaining ongoing challenge in the field of 
xylose utilization in yeast. 
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Chapter 6:  Conclusions and Future Work  
For years, when metabolic engineers attempt to produce biochemicals using 
microbial systems, glucose was the presumed carbon source. Other carbon sources like 
glycerol or ethanol are only used when they alter the metabolite balance and thus result in 
higher yield. However, the addition of those chemicals makes the production process 
unprofitable for industrial production. While it is widely known that xylose is the second 
most abundant sugar in lignocellulosic hydrolysate, xylose utilization is infrequently 
studied in unconventional yeasts other than simply importing a heterologous xylose 
pathway into these organisms. In this study, a combination of modern and classical 
methods was used to enable the non-conventional yeast Yarrowia lipolytica to utilize 
xylose to produce its natural product-lipid, and also a diverse portfolio of other molecules. 
This work can be used as a guideline for future researchers to follow for enabling an 
unconventional yeast to produce biochemicals from a non-native carbon source.  
In chapter 2, we showed that heterologous xylose pathway complementation into a 
new organism does not always result in robust xylose utilization. In this case, it was 
necessary to utilize a starvation adaptation method to activate the xylose pathway genes. 
Subsequent genome sequencing found that this higher expression level is not due to any 
single mutation, but duplication of the pathway genes. This starvation adaptation process 
is replicable in different strain background. The resulting strain can produce up to 15g/L 
lipid in bioreactor setting. This was among one of the first studies published able to activate 
the xylose pathway in Y. lipolytica, and the first study to report the large scale genome 
rearrangement. This project opened up the possibility for the rest of the chapters, and the 
genome replication can also be an interesting separate project in the future.  
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Based on the strains obtained in chapter 2, we further tested targets that were 
previously studied in a more common yeast, S. cerevisiae. These results suggested that 
only xylulose kinase is the bottle neck for xylose utilization in Y. lipolytica. This result 
showed that metabolic regulation in different yeast are very different and targets found 
through model organisms are not universal. One potential future direction to continue 
improving xylose in this host is to use CRISPR or the piggyBac system to identify other 
potential targets which promotes xylose utilization that are unique to Y. lipolytica. 
In addition to native lipids as a product, this work also showed that Y. lipolytica can 
use xylose to produce other chemicals like α-linolenic acid, riboflavin, and triacetic acid 
lactone through a yeast mating approach. The mating phenotype of Y. lipolytica has been 
well studied. But using mating to combine phenotypes of different strains has never been 
demonstrated in Y. lipolytica. These results demonstrate that the mating approach is 
astonishingly effective. The mated diploid strains showed a very high level of productivity 
and stability. Therefore, this mating approach should be considered more frequently as 
researchers try to expand carbon source for microorganisms, especially when a cellular 
adaptation step is required. Future work in this project area includes testing whether 
constructing strains without sporulation gene can create diploid strains with higher 
stability. Furthermore, a broader collection of xylose utilizing strains can be created to 
match with different biochemical production strains to achieve highest productivity. Put 
another way, not all applications will want to have a lipid producing strain as the mating 
partner.  
Finally, in Chapter 5, we attempt to further improve xylose utilization by 
engineering membrane transporter proteins to enable glucose/xylose co-utilization. The 
mutant transporter showed preference of xylose with no glucose inhibition in a S. 
cerevisiae strain. This work demonstrated, for the first time, that a predominant glucose 
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transporter can be evolved to have its preference shift to xylose, even at that exclusion of 
glucose. This transporter needs to be further tested in Y. lipolytica (as well as other strains) 
as the next step to further improve sugar co-utilization by fungi. 
Overall, these studies prove that xylose can serve as a major carbon source for the 
production of many biochemicals beyond ethanol. Furthermore, many of the approaches 
used in this work can be generalized to other organisms or carbon sources.  
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Chapter 7: Materials and methods 
7.1 METHODS FOR CHAPTER 2 
7.1.1 Strains and plasmids 
A list of the plasmids and strains used in this study is provided in Table 7-1. 
Escherichia coli strain DH10β was used for cloning and plasmid propagation. The list of 
primers used in this study is shown in Table 7-2. E26 strain is an evolved Y. lipolytica strain 
that can efficiently transform glucose into lipid (Liu et al. 2015b). The same strain with 
recovered LEU2 and URA3 was used for integration. XYL1 and XYL2, or XylA and XYL3 
were cloned into pUCS integration plasmids respectively(Blazeck et al. 2014). The 
sequences of XYL1, XYL2, XylA and XYL3 are codon optimized for Y. lipolytica.  In pUCS 
plasmids, the inserted genes were driven by a strong hybrid promoter and the whole 
expression cassettes were flanked by 26S ribosomal DNA regions, to target for higher 
integration efficiency (Blazeck et al. 2013b, 2014). Linearized integration plasmids with 
xylose utilization pathway were transformed into Y. lipolytica cells, and then selected on 






Table 7-1: List of plasmids and strains used in Chapter 2. 
   
Plasmids/strains  Description  
Plasmids   
pUCS1-16TEF-XYL1 Integration plasmid of XYL1with URA3 
pUCS2-16TEF-XYL2 Integration plasmid of XYL2with LEU2 
pUCS1-16TEF-XylA3 Integration plasmid of XylA3with URA3 
pUCS2-16TEF-XYL3 Integration plasmid of XYL3with LEU2 
pUC19-Actin-XYL1-XYL2-Tail  
Y. lipolytica strains   
PO1f Control strain 
E26 Base strain  
E26 leu- ura- E26 strain with LEU2 and URA3 knockout 
by Cre recombinase 
E26 XYL12 E26 leu- ura- with XYL1 and XYL2 
integrated into genome 





Table 7-2: List of primers used in Chapter 2. 
Genes Primers Sequences 




















Tail PCR primers 
 
Xyl1 Xyl1 SP1 D CCCATGGGACTGGGACAAGA 
 
Xyl1 SP2 D TTCCTATCTTCGTCTAAGAA 
 
Xyl1 SP3 D GGTTGCTTTATAGAGAGGAA 
Xyl2 Xyl2 SP1 D TACGACTTGGTCAGAGCCG 
 
Xyl2 SP2 D TAAGGGTGCTGTCAAGTGTC 
 
Xyl2 SP3 D TCATTGACGGCCCTGAGTAA 
26S 26S D CTTCCTATCATACCGAAGCA 
RT-PCR primers 
 
Actin Actin fwd AGTCCAACCGAGAGAAGATG 
 
Actin rev GGGGAGAGAGAAACCAGAG 
Xyl1 Xyl1 fwd CACCGCTTACTCTTCGTTC 
 
Xyl1 rev AGCCTTGATAGTTTCGTTCTC 
Xyl2 Xyl2 fwd CTGCTGTTGGAATCTTTGAC 
 
Xyl2 rev GCGTCCTTGAACTTGTATCTG 
C chromosome 
tail region 
C chrom fwd CAAAACACCACGGTAATCGG  
 
C chrom rev ACAGCAACTACTCCTTTCAC 
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7.1.2 Medium and cell culturing  
E. coli strains were cultured in Lysogeny broth (LB) media supplemented with 100 
μg/mL ampicillin. For integrating xylose pathway genes, 6.7 g/L Yeast Nitrogen Base 
(YNB) w/ammonia sulfate w/o amino acids (Becton, Dickinson, and Company) and 0.79 
g/L Complete Supplement Mixture (CSM) –Leu –Ura (MP Biomedicals) and 20 g/L 
glucose was used for selection. For genomic copy number and expression level 
characterization, YNB with complete CSM was formulated with 20 g/L glucose or xylose. 
For characterizing growth in 50 mL flasks, only YNB was used with the corresponding 
carbon source. YPD media (yeast extract, peptone and dextrose) was used for testing strain 
stability. YNB with 10 g/L ammonium sulfate and 160 g/L xylose was used in bioreactor 
fermentations. 
E. coli cultures were grown at 37 ̊C with constant shaking at 225 rpm. Small 
volumes of Y. lipolytica were grown in 3 mL media at 30 ̊C with 225 rpm shaking. Medium 
volume cultures were grown at 50 mL volume in 125 mL flasks under same conditions. 
7.1.3 Bioreactor fermentations 
Minimal media with only YNB and xylose were used to run large scale bioreactor 
fermentations. Batches of 1.5 L fermentations in 2 L bioreactors were inoculated to initial 
OD600 at 0.1. The temperature was maintained at 28 ̊C. and pH was maintained no lower 
than 3.5 with 1 M NaOH. The dissolved oxygen level was maintained at 50% air saturation 
by varying agitator speed between 250 rpm and 800 rpm with a constant air input flowrate 
of 3.75 L/min. 10 mL samples were taken every 24 hours; OD600, sugar concentration and 
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lipid production were measured for each time point. The entire fermentations lasted 216 
hours. The model of bioreactors we used was New Brunswick™ BioFlo®/CelliGen® 115.  
 
7.1.4 Cell starvation 
Y. lipolytica strains E26 or PO1f with integrated XYL1, XYL2 or XylA, XYL3 were 
grow up in 3 mL YNB + CSM+20 g/L glucose at 30 ̊C and 225 rpm in a culture tube for 
14 days. Then cells were washed with water and then inoculated into 50 mL CSM + xylose 
(20 g/L). Cell culture of E26 XYL1XYL2 that used up xylose was streaked out on YPD 
plates to select for single colonies. 20 colonies were selected then grown up in 3 mL YPD. 
The grown up cell culture were inoculated onto YNB + CSM + 20 g/L xylose plates to 
select for strains with stable ability to use xylose. Seven strains were picked and glycerol 
stocked for further characterization. 
7.1.5 HPLC AND GC ANALYSIS 
Glucose and xylose concentrations were measured with HPLC. Supernatant from 1 
mL samples were filtered through 0.2 μm filters prior to running HPLC. A Thermo 
Scientific Dionex UltiMate 3000 Rapid Separation LC (RSLC) system, with RefractoMax 
521 Refractive Index Detector and Aminex HPX-87P Column were used to measure 
samples. Filtered and degassed H2O was used as mobile phase. The flow rate of mobile 
phase was 0.6 mL/min. The column was kept at 85 ̊C.  Lipid samples were extracted and 
prepared following the procedures described in Liu L. et al (Liu et al. 2015a). TRACE™ 
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1310 Gas Chromatograph was used for measuring lipid samples. Hexane was used as 
solvent for esterified fatty acids. 
7.1.6 TAIL-PCR 
To determine integration sites of XYL1 and XYL2, TAIL-PCR was performed 
according to protocol previously described (Liu and Whittier 1995). Primers near 3’ ends 
of XYL1 and XYL2 were paired with degenerate primers to amply 3’ end of integration 
locus on genomic DNA. Three rounds of amplification were performed for each strain, and 
the amplified products were purified and sequenced by Sanger sequencing.   
7.1.7 RT-PCR 
RiboPure™ RNA Purification Kit (yeast) from ThermoFisher Scientific was used 
to extract total RNAs from Y. lipolytica samples. High-Capacity cDNA Reverse 
Transcription Kit from ThermoFisher Scientific was then used to convert mRNA into 
cDNA. Wizard® Genomic DNA Purification Kit from Promega was used for genomic 
DNA extraction. FastStart SYBR Green Master from Roche was used for RT-PCR. A 
plasmid constructed from pUC19 with actin (YALI0D08272g), XYL1 and XYL2 were used 
for generating standard reference curve. Copy numbers were calculated using the standard 
curve, and then XYL1 and XYL2 relative copy numbers of expression were plotted against 
copy numbers of actin driven by its native promoter.  
7.1.8 Bioinformatics 
Illumina HiSeq 2500 Run pair end sequencing PE 2X125 was used to sequence 
genomic DNA extracted from strain E26 XUS. The HiSeq generated 25,337,178 read pairs 
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that covered the Y. lipolytica genome approximately 225 times. The sequencing results 
were mapped to the CLIB122 genome using BWA; and Samtools, BEDTools and IGV 
were used to analyze the data (Li and Durbin 2009; Li et al. 2009; Quinlan and Hall 2010; 
Meacham et al. 2011).  
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CHAPTER 7.2 METHODS FOR CHAPTER 3 
 
7.2.1 Strains and plasmids 
Y. lipolytica strains used in this study are described in Table 7-3. Escherichia coli strain 
DH10β were used for cloning. Plasmids used in this study is provided in Table 7-4. PO1f 
XUS was described in prior publication (Li and Alper 2016) and briefly described here. 
PO1f Xylose Utilizing Strain (XUS) was generated by integrating Xyl1 and Xyl2 into the 
genome of the respective background strain followed by a starvation adaptation that 
resulted in increased copy number and expression (Li and Alper 2016). Primers and 
codon optimized spXYL1.2 was synthesized by IDT (Integrated DNA technologies).  
 
Table 7-3. List of strains used in Chapter 3. 
Strain name Genotype 
PO1f XUS PO1f 4xXYL1 4xXYL2  
PO1f XUS XKS PO1f 4xXYL1 4xXYL2 ylXKS 
PO1f XUS TAL PO1f 4xXYL1 4xXYL2 ylTAL  
PO1f XUS TKL PO1f 4xXYL1 4xXYL2 ylTKL  
PO1f XUS RKI PO1f 4xXYL1 4xXYL2 ylRKI  
PO1f XUS RPE PO1f 4xXYL1 4xXYL2 ylRPE  
PO1f XUS XKS TAL PO1f 4xXYL1 4xXYL2 ylXKS ylTAL  
PO1f XUS XKS TKL PO1f 4xXYL1 4xXYL2 ylXKS ylTKL  
PO1f XUS XKS TAL 
TKL 
PO1f 4xXYL1 4xXYL2 ylXKS ylTAL ylTKL  
PO1f XUS XKS YEF PO1f 4xXYL1 4xXYL2 ylXKS ylYEF1 
PO1j XYL1 XYL2 XKS PO1j 1xXYL1 1xXYL2 ylXKS 
PO1j XYL1.2 XYL2 XKS PO1j 1xspXYL1.2 1xXYL2 ylXKS 
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Table 7-4. List of plasmids used in this Chapter 3. 
 
Plasmid name Function 
pUC-Hph-ylXKS ylXKS integration plasmid 
pUC-Hph-ylTAL ylTAL integration plasmid 
pUC-Hph-ylTKL ylTKL integration plasmid 
pUC-Hph-ylRPE ylRPE integration plasmid 
pUC-Hph-ylRKI ylRKI integration plasmid 
pUC-NAT-ylTAL ylTAL integration plasmid 
pUC-NAT-ylTKL ylTKL integration plasmid 
pUC-GuaB-ylTKL ylTKL integration plasmid 
pUC-NAT-ylYEF1 ylYEF1 integration plasmid 
pUCS3-spXYL1.2 spXYL1.2 integration plasmid 
pUCS3-XYL1 XYL1 integration plasmid 
pUCS2-XYL2 XYL2 integration plasmid 
 
7.2.2 Media conditions 
E. coli strains were cultured in Lysogeny broth (LB) media supplemented with 100 
μg/mL ampicillin at 37°C. For cultivation of Y. lipolytica, YSC media with 40 g/L 
xylose, 0.79 g/L CSM-Complete (MP Biomedicals), and 6.7 g/L Yeast Nitrogen Base 
(Becton, Dickinson, and Company) was used for flask fermentation. Y. lipolytica flask 
fermentations were routinely performed at 28°C in 250 ml flasks with 225 rpm shaking. 
Yeast Peptone Glucose media (YPD) containing 10 g/L yeast extract, 20 g/L peptone and 




Sugar concentrations were measured using a Thermo Scientific Dionex UltiMate 
3000 Rapid Separation LC (RSLC) system with UV detector or RefractoMax 521 
Refractive Index Detector as required. This measurement was likewise conducted as 
previously described without modification (Li and Alper 2016). 
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CHAPTER 7.3 METHODS FOR CHAPTER 4 
 
7.3.1 Strains and plasmids 
Y. lipolytica strains used in this study are described in Table 7-5. Escherichia coli 
strain DH10β were used for cloning. Plasmids used in this study is provided in Table 7-6. 
Y. lipolytica strains E26 XUS, ALA-A, RIB-A and TAL-A were described in prior 
publications and briefly described here (Li and Alper 2016; Cordova and Alper 2018; 
Markham et al. 2018; Wagner et al. 2018). E26 Xylose Utilizing Strain (XUS) were 
generated by integrating Xyl1 and Xyl2 into the genome of the respective background 
strain followed by a starvation adaptation that resulted in increased copy number and 
expression (Li and Alper 2016). ALA-A strain overproduces α-linolenic acid and was 
generated by integrating multiple copies of RkD12-15 into the background strain 
L36DGA1 (Cordova and Alper 2018). RIB-A strain overproduces riboflavin and was 
generated by overexpression of RIB1 and RIB3 followed by multiple rounds of 
mutagenesis and selection (Wagner et al. 2018). TAL-A strain overproduces triacetic 
acid lactone and was constructed by first integrating 4 copies of the polyketide synthase, 
g2ps1, followed by an overexpression of ACS1, ALD5, PDC2 and ACC1 (Markham et 
al. 2018). XUS-B mKate and PO1f-A hrGFP strains were generated in this study by 
integrating mKate2 or hrGFP with integration plasmid and overexpressing with a strong 
hybrid promoter.  
Donor DNA for the mating region including MATB1 and MATB2 was 
synthesized by IDT using the sequence annotated for strain CLIB122. This synthesized 
sequence was then cloned alongside a NAT marker flanked by the piggyBac ITR 
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sequence. Finally, 1 kb of upstream and downstream homology sequence was cloned to 
match the mating region. The overall sequence for this construct is provided in Table 7-7. 
The entire integration cassette was PCR amplified into two sections using a homology 
overlap region in the NAT marker prior to transforming into the xylose utilizing mating 
type A strains via electroporation (Markham, Vazquez and Alper 2018). Putative 
transformants were selected on a YPX+NAT plate, and confirmed by PCR from outside 
the homologous region. A plasmid expressing excision-only version of piggyBac 
transposase was then transformed into this strain to remove NAT marker as per 
previously reported (Wagner, Williams and Alper 2018). Positive confirmation of the 
NAT removed strain was confirmed by PCR with primers outside of homologous region. 
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Table 7-5. List of strains used in Chapter 4. 
 
STRAIN NAME GENOTYPE 
E26 XUS E26 4xXYL1 4xXYL2 MATA1 MATA2 
E26 XUS XKS  E26 4xXYL1 4xXYL2 ylXKS MATA1 MATA2 
XUS-B E26 4xXYL1 4xXYL2 ylXKS MATB1 MATB2 
XUS-B MKATE  E26 4xXYL1 4xXYL2 ylXKS mKATE2 MATB1 MATB2  
PO1F-A HRGFP PO1f hrGFP MATA1 MATA2 
ALA-A L36DGA1 2xRkD12–15 MATA1 MATA2 
RIB-A PO1f RIB1 RIB3 
TAL-A PO1f 4xg2ps1 ACS1 ALD5 PDC2 ACC1 
 
Table 7-6. List of plasmids used in Chapter 4 
PLASMID NAME FUNCTION 
PUC-NAT-MKATE2 mKate2 integration plasmid 
PUC-GUAB-HRGFP huGFP integration plasmid 
PUC-MATB CASSETTE PART I  Mating type switch plasmid 
PUC-MATB CASSETTE PART II  Mating type switch plasmid 
















































Table 7-7 continued. Sequence of MATB1 and MATB2 region with 1kb upstream 












































Table 7-7 continued. Sequence of MATB1 and MATB2 region with 1kb upstream 





























7.3.2 Media conditions 
E. coli strains were cultured in Lysogeny broth (LB) media supplemented with 
100 μg/mL ampicillin at 37°C. For cultivation of Y. lipolytica, YSC media with 40 g/L 
glucose or xylose, 0.79 g/L CSM-Complete (MP Biomedicals), and 6.7 g/L Yeast 
Nitrogen Base (Becton, Dickinson, and Company) was used for flask fermentation. Y. 
lipolytica flask fermentations were routinely performed at 28°C in 250 ml flasks with 225 
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rpm shaking. The ALA flask experiment was performed at 20 °C. Yeast Peptone Glucose 
or Xylose media (YPD or YPX) containing 10 g/L yeast extract, 20 g/L peptone and 20 
g/L glucose or xylose was used to prepare cells for transformation or mating. YPX with 
double amount of xylose was used for ALA flask experiment. Yeast extract – malt 
medium (YM) consisting of 5 g/L peptone, 3 g/L yeast extract and 3 g/L malt extract 
(Austin Homebrew Supply) was used for mating.   
 
7.3.3 Mating method 
The mating method utilized here was adapted from a previously reported protocol 
(Barth & Gaillardin, 1996) with modifications. Briefly, parental strains were grown in 2 
mL YPD media at 28 °C in tubes overnight, then 1 mL of each culture was combined into 
a fresh tube. The mixed cells were rinsed with YM medium and then resuspended in 10 
mL YM medium. This mixture was incubated at 28°C without shaking for 1-4 days 
depending on strains used. Mating efficiency varies due do different parental strains used. 
The mated culture from different dates was plated on YPX with 1 mg/ml nourseothricin 
for selection. Isolated colonies were then purified by re-streaking onto fresh plates. The 
ploidy was confirmed using internal primers embedded in matA1 matA2 and matB1 
matB2 genes.  
To measure conjugation frequency, XUS-B mKate and PO1f-A hrGFP were 
mated according to the protocol described above. Both parental strains as well as the 
mated culture were enriched in YPD media for overexpression of the fluorescent 
proteins. The enriched cultures were run on flow cytometry (BD Accuri™ C6 Plus flow 
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cytometer) as well as the original cell mix before conjugation event occur. The parental 
strains were used for compensation and the original cell mix was used as reference to 
calibrate the growth rate difference. The diploid cells are the population that have 
fluorescence of both fluorescent proteins. 
7.3.4 Bioreactor fermentation 
We performed bioreactor fermentation as previously described (Cordova and 
Alper 2018), however, xylose was used in place of glucose (with the same mass 
concentrations used for the fermentation). Initial media contained 0.79 g/L CSM-
Complete, 3.4 g/L Yeast Nitrogen Base and 80 g/L xylose. The bioreactor was inoculated 
with an initial concentration of 0.1 OD600 unit. As additional 80 g of xylose was added 
after the 72-hour timepoint to be consistent with the previous, glucose ALA bioreactor 
fermentations conditions. The total volume in the reactor was 1.7 L after the xylose 
addition. The pH of the bioreactor was single-sided control with 1 M NaOH to keep the 
value greater than 3.5 and dissolved oxygen was controlled to be no less than 50% 
saturation using an agitator cascade (maximum 800 rpm, minimum 250 rpm). The model 
of bioreactors used in this study was New Brunswick™ BioFlo®/CelliGen® 115. 
 
7.3.5 Product analysis 
Lipid content including ALA was extracted and analyzed using GC mass 
spectrometry (TRACE™ 1310 Gas Chromatograph) as previously described without 
modification (Cordova and Alper 2018). Riboflavin was measured at 450 nm wavelength 
using a spectrophotometer as described by Wagner et al. without modification (Wagner 
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et al. 2018). TAL and sugar concentrations were measured using a Thermo Scientific 
Dionex UltiMate 3000 Rapid Separation LC (RSLC) system with UV detector or 
RefractoMax 521 Refractive Index Detector as required. TAL was measured using C18 
reverse flow column and glucose or xylose were measured using HPX-87P Column. 
These measurements were likewise conducted as previously described without 
modification (Li and Alper 2016; Markham et al. 2018). 
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CHAPTER 7.4 METHODS FOR CHAPTER 5 
 
7.4.1 Strains, plasmids and media 
S. cerevisiae EBY.VW4000 strain was provided by Dr. Eckhard Boles of the 
Institute of Molecular Biosciences, Goethe-Universität, at Frankfurt, Germany. Strain 
ETKX was constructed by deleting HXK1, HXK2 and GLK1 in EBY.VW4000. Plasmids 
p416GPD-X1X2X3 and p415Gal1p-Gal2 were transformed into ETKX strain to build 
strain ETKXG. ETKXG was able to grow on galactose and xylose but not glucose, and 
was used for testing and selecting xylose transporters. CiGXS1 transporters were 
subcloned into plasmid p414TEF. Quick Change PCR primers (Table 7-8) were used for 
making single mutations. CiGXS1 fwd primer were paired with C-terminus truncation 
primers (Table 7-8) to make seven transporters with different C-terminus tail lengths. The 
xylose utilization pathway was expressed in EBY.VW400 on plasmid p416GPD-X1X2X3. 
The resulting strain EBYX was used for characterizing the glucose and xylose co-
utilization. In the co-utilization test, WT, FIM and FIVFH497* were expressed using the 
GPD promoter in plasmid p414GPD. All yeast shuttle vectors were previously described 
by Mumberg et al. (1995). Yeast strains were grown on Yeast Nitrogen Base (YNB) with 
ammonia sulfate without amino acids (Becton, Dickinson and Company. Sparks, MD 
USA), Complete Supplement Mixture (CSM) with certain dropout to maintain plasmids 
with selecting carbon sources. Escherichia coli strain DH10β (New England BioLabs, 
Ipswich, MA) was used for cloning and plasmid propagation and were cultured in 
Lysogeny broth (LB) media containing 100 μg/mL ampicillin.  
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Table 7-8. List of primers used in Chapter 5. 
Mutagenesis primers Sequences 
 CiGXS1 fwd GATTCTAGAACTAGTGGATCCATG 
 CiGXS1 rev GGTCGACGGTATCGATTTA 
 
Quick Change PCR primers 
T170N C509A fwd GGAATAGTAGAACCGACATGGACAATGTTAGTGGCC
AAG 
 C509A rev CTTGGCCACTAACATTGTCCATGTCGGTTCTACTATTC
C 
N326H A976C fwd GCCAAGAAAAGACCAATGTTAATAGCCCACTGGTAA
CAA 
 A976C rev TTGTTACCAGTGGGCTATTAACATTGGTCTTTTCTTGG
C 
N326F A976T A977T fwd GGAATAGTAGAACCGACAAAGACAATGTTAGTGGCC
AAG 
 A976T A977T rev CTTGGCCACTAACATTGTCTTTGTCGGTTCTACTATTC
C 
M40V A118G fwd TGCTTCTGGTGGTTTCATTGTGGGATACGATACTGGT
AC 
 A118G rev GTACCAGTATCGTATCCCACAATGAAACCACCAGAAG
CA 
 
C-terminus truncation primers 
 Y467* rev AAAAAAATCGATCTAGATGAAGTACCAAGCGAAGA 
 V477* rev AAAAAAAATCGATCTACTGCTCCAAAGAAAGACCC 
 A487* rev AAAAAAAATCGATCTACTTGCTGACATGCTCGTAC 
 K497* rev AAAAAAAAAATCGATTTAAGATGGAACGAAGCCCT 
 E502* rev AAAAAATCGATCTACTCTCTGAAAGAGTGCTTAGATG 
 Q507* rev AAAAAAAAAATCGATTTACTGGTCCACCTGCTCTC 
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7.4.2 Directed evolution 
Random mutagenesis of C. intermedia GXS1 using mutagenesis primers (Table 
7-8) was accomplished with Gene-morph Mutazyme II kit (Agilent Technologies, Santa 
Clara, CA). Mutagenesis libraries were constructed as previously described (Young et al. 
2012). These libraries were then transformed into S. cerevisiae ETKXG. The first three 
rounds of libraries were plated on CSM-Ura Leu Trp minimal medium with 20 g/L 
xylose and 20/40/60 g/L glucose plates. Large colonies were then tested again in 3 ml of 
the same media in culture tubes in parallel with their parental strain to confirm for better 
growth. In the fourth round of mutagenesis, the yeast strain transformed with transporter 
library was grown in 50 mL shake flask with CSM-Ura Leu Trp minimal medium with 
20 g/L xylose and 60 g/L glucose. The combined culture went under three rounds of 
dilution before plating on plates for single colonies. Strains with confirmed better growth 
were sequenced to check for mutations. 
 
7.4.3 Growth condition 
E. coli cultures were grown at 37 ̊C with constant shaking at 225 rpm. S. cerevisiae 
were grown in 3 mL media in 14 mL culture tube or 50 mL in 125 mL flask at 30 ̊C with 
225 rpm shaking. For deep well assay, yeast strains were grown in 1.4 mL media in 96 well 
deep-well plates with 1.8 mL capacity for each well. The deep-well plates were incubated 
at 30 ̊C with 1000 rpm shaking. 100 μL samples were taken every 24 hours and relative 
OD600 was measured in clear bottom 96 well plates using plate reader.  
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7.4.4 High Cell Density Flask fermentation 
Strain EBYX transformed with p414TEF-CiGXS1 wild type transporter, FIM and 
FIVFH497* mutants was first grown in CSM-Ura Leu with 20 g/L xylose as start culture. 
Cells were then washed and inoculated into 50 mL of CSM-Ura Leu with 10 g/L xylose 
and 10 g/L glucose. The initial OD for the flask fermentation was 3 for each flask. Sample 
were taken every 24 hours to measure OD and sugar content.  
 
7.4.5 HPLC analysis of sugars 
Glucose and xylose concentrations were measured using HPLC. Supernatant from 
1 mL samples were filtered through 0.2 μm filters prior to running HPLC. A Thermo 
Scientific Dionex UltiMate 3000 Rapid Separation LC (RSLC) system (Sunnyvale, CA 
USA), with RefractoMax 521 Refractive Index Detector (Kawaguchi, Saitama Japan), and 
Aminex HPX-87P Column (Hercules, CA USA) were used to measure samples. Filtered 
and degassed H2O was used as mobile phase, with a flow rate of 0.6 mL/min. The column 
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